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FOREWORD
The Life Sciences Research Office (LSRO), Federation of
American Societies for Experimental Biology (FASEB), provides
scientific assessments of topics in the biomedical sciences.
Reports are based upon comprehensive literature reviews and the
scientific opinions of knowledgeable investigators engaged in work
in specific areas of biology and medicine.
This technical report was developed for the National
Aeronautics and Space Administration (NASA) in accordance with the
provisions of Contract NASW 3728. It was prepared and edited by
Gerald J. Herbison, M.D. , Department of Rehabilitative Medicine,
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania,
who served as Key Biomedical Scientist for this effort and John M.
Talbot, M.D., Senior Medical Consultant, LSRO.
The LSRO acknowledges the contributions of the investi-
gators and consultants who assisted with this study. The report
reflects the opinions expressed by an ad hoc study group that met
at the Federation on July 18-19, 1983. The study participants
reviewed a draft of the report and their various viewpoints were
incorporated into the final report. The study participants and
LSRO accept responsibility for the accuracy of the report; however,
the listing of these individuals in Section VIII does not imply
that they specifically endorse each study conclusion.
The report was reviewed and approved by the LSRO Advisory
Committee (which consists of representatives of each constituent
Society of FASEB) under authority delegated by the Executive Com-
mittee of the Federation Board. Upon completion of these review
procedures, the report was approved and transmitted to NASA by the
Executive Director, FASEB.
While this is a report of the Federation of American
Societies for Experimental Biology, it does not necessarily reflect
the opinion of each individual member of the FASEB constituent
Societies.
(dafe) Kenneth D. Fisher, Ph.D.
Director
Life Sciences Research Office
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SUMMARY
Atrophy of skeletal muscles, especially of those used
for locomotion, maintaining posture, and counteracting gravity on
Earth, occurs during space flight. When the gravitational loading
of the musculoskeletal system is removed, as in weightlessness,
one of the body's responses is muscle atrophy, particularly in the
legs and thighs. This is reflected by a reduction of muscle vol-
ume, mass, strength, exercise capacity, and neuromuscular coordina-
tion. Metabolic manifestations of disturbed protein turnover in
the muscles of space travelers include marginal or negative bal-
ances of nitrogen and potassium, as well as a persistent rise in
urinary excretion of nitrogen, ammo acids, and 3-methylhistidine.
Although there are no reports that muscle atrophy associ-
ated with space flight has compromised any manned mission to date,
decrements in strength, exercise capacity, and locomotor coordina-
tion have been observed after most manned space missions. More-
over, muscular deconditioning may have contributed to the tachy-
cardia noted during extravehicular activity in the Gemini, Apollo,
and Skylab programs and to the cardiac arrhythmias and marked
fatigue experienced during lunar surface activities and return to
Earth in the Apollo 15 mission. Full recovery of muscular strength
following space flights of medium (weeks) to long (months) dura-
tion requires from several days to several weeks. Data are not
available to show conclusively whether full recovery of muscle
bulk takes place.
In the weightlessness of orbital flight, the functional
load on the musculoskeletal system is insufficient to maintain
normal physiologic status of the musculature. There is no need
for muscular opposition to gravity or for maintaining terrestrial
posture, and the effort needed to move about is greatly reduced.
The types of physical performance required of astronauts (except
for voluntary physical exercises) and the confined volume of their
spacecraft contribute to a marked reduction of physical activity.
Whether the muscle atrophy is caused by zero-G or a combination of
factors in the spacecraft environment has not been fully estab-
lished, but weightlessness seems to be the dominant etiologic fac-
tor. Lack of production of customary muscular force in zero-G i^s
probably an important contributory factor, and deviations from
normal hormonal balances may influence muscle protein turnover.
Daily regimens of vigorous physical exercises during
space missions are used by both U.S. and U.S.S.R. spacecrews as a
means of counteracting muscle atrophy. Inflight diets are formu-
lated to provide all required nutrients to maintain positive nitro-
gen and energy balance. In addition, Soviet inflight preventive
measures include electrostimulation of muscles and wearing a
motion-resisting garment. However, despite these measures, skele-
tal muscle atrophy continues to progress during space flight,
resulting in progressive loss of muscle and negative nitrogen
balance.
Although scientific knowledge about the physiologic and
pathologic effects of use and "disuse" of skeletal muscle is abun-
dant, there is still much to be learned. Lack of data on the
basic biologic mechanisms of muscle atrophy and hypertrophy ham-
pers the quest for a solution to the problem of muscle atrophy in
space. Consequently, the National Aeronautics and Space Adminis-
tration (NASA) supports research on the basic mechanisms of muscle
atrophy and efficient methods of prevention or control. The pres-
ent report is part of an effort by NASA to identify promising
lines of research for future program planning. It is based upon a
review of available knowledge and the opinions and suggestions of
a group of expert investigators (the LSRO ad hoc Working Group on
Muscle Atrophy) whose names are listed on page 81.
The report includes background information on muscle biol-
ogy and atrophy, a review of muscle atrophy associated with actual
and simulated space flight, and the findings of the ad hoc Group
with respect to important gaps in knowledge, desirable research
approaches, and the present NASA research program on muscle atro-
phy. A majority of the participants concluded that acquisition of
essential data from inflight measurements of spacecrew personnel
is important for designing more meaningful ground-based and in-
flight experiments. Such measurements should be representative of
a typical day's activities. They would be practical, designed not
to interfere with crew duties, and would assess muscle strength,
velocity of contraction, levels of electrical activity, and fatiga-
bility. The data would be compared with results of measurements
of the same parameters in the same individuals in a typical day of
ground activity.
Suggested approaches to determining basic mechanisms of
disuse atrophy involve studies of: (1) the effects on muscle pro-
tein turnover of altered tissue concentrations of and sensitivi-
ties to anabolic hormones such as growth hormone and the somato-
medins; (2) promoters of muscle protein synthesis such as leucine,
other branched chain amino acids, and their metabolites; (3) iden-
tification and characterization of the enzymes responsible for
changes in rates of muscle protein synthesis and degradation in
response to unloading and relative inactivity; and (4) identifica-
tion and test of inhibitors of muscle proteases. A major break-
through would be discovery of the molecular stimuli that lead to
changes in rates of muscle protein synthesis and degradation in
response to increased or decreased use of skeletal muscle.
VI
Use of the rat head-down suspension model for inducing
hypokinesia and hypodynamia of the hind limbs has yielded experi-
mental results on muscle atrophy similar to those derived from
studies inflight. While this is a good model for ground-based
studies, efforts should continue to develop and improve models for
simulating zero-G, including comparative studies of such methods
as joint pinning, casting, paraplegia, denervation, and pharmaco-
logic nerve block. Human patients with spinal cord injury might
be tested ethically to determine the minimum amount of electri-
cally-induced exercise that would prevent muscle atrophy; data
from such tests could be used in designing inflight exercises.
To acquire other data for improving inflight exercises,
pre- and postflight measurements of maximal voluntary contractions
of selected muscle groups such as the flexors and extensors of the
arms and legs should be done on all personnel who participate in
space flights. Complementary ground-based studies in a model of
hypokinesia/hypodynamia such as bed rest should be done with human
subjects to determine minimum amounts of strength or endurance
exercises, or combinations of these, needed to prevent muscle atro-
phy. The role of eccentric contractions for maintaining muscle
strength and bulk in models of hypokinesia/hypodynamia should be
explored. Finally, more data are needed to settle questions
related to optimal preflight physical fitness of space flyers.
Examination of NASA's research on muscle atrophy indi-
cates that it is a young, evolving program based on expert guid-
ance received from multiple sources including formal scientific
advisory groups. Most studies in the Biomedical Research Program
on Muscle Atrophy are consistent with the governing program docu-
ments. However, future program planning should include refine-
ment, if possible, of the research objectives and approaches and
closer matching of these with ongoing and planned research. The
Biomedical Research Program on Muscle Atrophy is complemented by
other valuable ground-based studies in the Space Biology Program
and by muscle studies scheduled for Spacelab 4. Finally, the
ad hoc Working Group on Muscle Atrophy concluded that the research
suggestions in this report offer opportunities for future planning
that would enhance the likelihood of achieving NASA's objectives
in muscle atrophy research.
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I. INTRODUCTION
One of the problems addressed by the Biomedical Research
Program of the National Aeronautics and Space Administration (NASA)
is the atrophy of skeletal muscles that occurs during space flight.
Numerous observations of American and Soviet space travelers, ani-
mals flown in space, and subjects exposed to simulated weightless-
ness have generally demonstrated skeletal muscle atrophy. Associ-
ated effects include decreased muscle strength and reduced work
capacity (Pestov and Geratewohl, 1975). The biomedical results of
the Gemini, Apollo, and Skylab programs included several features
in common that were referable directly or indirectly to skeletal
muscle effects: minimal to moderate loss of muscle nitrogen,
weight loss, and postflight decrease in exercise tolerance
(Dietlein, 1977). Similar effects have been reported by Soviet
space medical scientists (Gazenko et al., 1981).
The muscle atrophy experienced to date, in missions from
a few weeks to six months, has apparently not compromised crew
effectiveness inflight and seems to be reversible following mis-
sion completion. Daily, vigorous exercises of the major muscle
groups appear to retard the muscle deconditioning; however, the
reliability and effectiveness of exercises have not been ade-
quately demonstrated from a scientific standpoint. In fact, some
evidence suggests that, despite all measures at intervention that
have been attempted, muscle atrophy continues throughout orbital
flight, featuring progressive loss of muscle mass and negative
nitrogen balance (Whedon, 1982; Whedon et al., 1977).
Although the muscle atrophy experienced to date by U.S.
astronauts appears to have been innocuous inflight, it may have
interfered to an unknown degree with the physiologic efficiency of
astronauts engaged in extravehicular activity including explora-
tion of the lunar surface. Postflight, it contributes to a tempo-
rarily reduced state of physical fitness and orthostatic intoler-
ance. In addition, leg volumes of astronauts are diminished upon
return to Earth. Thus, space-related muscle atrophy represents a
significant biomedical problem.
NASA's quest for a solution to this problem is hampered
by a lack of knowledge of the biologic mechanisms of muscle atro-
phy; hence, in a continuing effort to resolve the problem, NASA
supports intra- and extramural research ranging from basic studies
to applied technology. Part of NASA's responsibility in manage-
ment of research is to review and revise the research program
periodically in order to take advantage of new knowledge and
expert opinion. In connection with this process, NASA requested
that the Life Sciences Research Office (LSRO) of the Federation of
American Societies for Experimental Biology (FASEB) review and
evaluate available knowledge and ongoing research and provide
additional scientific input for future research programming in
muscle atrophy. This has been done with the assistance of an
ad hoc Working Group of outstanding scientists, supplemented by
other prominent investigators, who are identified in Section VIII
II. OBJECTIVES AND SCOPE OF THE STUDY
The objectives of the LSRO study of the problem of muscle
atrophy associated with space flight are:
(1) to review extant knowledge of the subject;
(2) to examine NASA's current and projected research
program;
(3) to identify all significant gaps in essential
knowledge;
(4) to formulate additional suggestions for future
research consideration by NASA; and,
(5) to produce a documented report of the foregoing
items that can be used for NASA research program
planning.
With respect to NASA's research and development in muscle
atrophy and methods of coping with the problem, the primary emphasis
in this report is on the ground-based Biomedical Research Program
on Muscle Atrophy. However, the review includes pertinent informa-
tion from NASA's Space Biology Program and the muscle experiments
planned for Spacelab 4. In addition, the report emphasizes the
essential importance of acquiring as soon as possible, human data
on muscle physiology during all inflight opportunities, and sug-
gests experiments that could be done with minimal encroachment
upon the schedules of the spacecrews.
The scope of topics that were reviewed, as is indicated
in the Table of Contents, covers the basic biologic disciplines,
certain clinical aspects, possible means of intervention, and the
areas of models, methods, and equipment. The major portion of the
report (Section V) is devoted to the observations of the ad hoc
Working Group during their meeting at FASEB and their follow-up
contributions including critiques of the draft report.
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III. ATROPHY OF SKELETAL MUSCLE
A. NORMAL MUSCLE
Only a small part of the literature in the broad field of
skeletal muscle biology is cited in the following paragraphs. Some
additional sources that are not cited in the report are appended
to the list of references (see p.79). Table 1 is an outline of
certain anatomic features of skeletal muscle. The muscles which
are of primary concern in this study include most of the muscles
of the lower extremities, the gluteal muscles, the trunk muscles,
extensors of back and neck, and their antagonists.
1. Muscle function
The sliding filament model is generally accepted as
the basic contractile system of striated muscle, and the sarco-
plasmic reticulum and transverse tubular system, in concert with
Ca2"1", link neuromuscular excitation and muscle contraction (Fuchs,
1974). The complex process of muscle contraction was outlined by
Fuchs (1974):
Briefly, force generation is believed to result
from the cyclic attachment and detachment of cross-
bridges projecting from the thick (myosin) filaments
and interacting with the thin (actin) filaments in
such a way as to draw them toward the center of the
sarcomere. Cross-bridge activity is energetically
coupled to the splitting of adenosine triphosphate
(ATP), catalyzed by the cross-bridges themselves,
and is regulated by the (free) Ca2"1" concentration in
the sarcoplasm. The sarcoplasmic reticulum (SR) mem-
branes contain an ATP-dependent Ca2+ pump which main-
tains the sarcoplasmic Ca2"1" concentration in resting
muscle at a level (<10~7M) below that needed for
activation of cross-bridge interaction. Upon stimu-
lation, an electrical signal is transmitted along
the transverse tubules (T-tubule) to the terminal
cisternae of the SR, thereby causing a rapid release
of Ca2"1" and an elevation of sarcoplasmic Ca2+ concen-
tration to 10-%. Cross-bridge attachment is pro-
moted by the binding of Ca2"1" to the thin filaments.
The activating effect of Ca2"1" is mediated by two pro-
teins, tropomyosin and troponin, bound to the thin
filaments. In the resting state, cross-bridge
attachment is inhibited by these two proteins, and
this inhibition is overcome only when Ca2+ binds to
the troponin. During the relaxation phase, Ca2"1" is
reaccumulated within the SR, and the cross-bridges
detach from the thin filaments.
Table 1. Outline of the Anatomy of Human Skeletal Muscle*
Anatomic Unit Description Dimension/Size
individual muscle collection of muscle fasciculi enclosed
in the muscle sheath (epimysium), with
integral blood supply and neural network
and attachments to tendons, aponeuroses,
or faciae
length: 2 mm->60 cm
(sartorius)
muscle fasciculus longitudinal bundles of 12 or more muscle
fibers enclosed by a collagenous, elastic
membrane, the perlmysium
muscle fiber a muscle includes thousands of generally
cylindrical fibers: large, elongated,
multi-nucleated cells enveloped by endo-
mesial connective tissue and consisting
of hundreds or thousands of myofibrils,
sarcoplasm, sarcoplasmic reticulum, mito-
chondria, and other common cellular elements
length: same as above
diameter: 10-100 m
myofibril each myofibril contains approximately 1500
myosin filaments and 3000 actin filaments
which interdigitate and are the contractile
elements of muscle
diameter: <<20 ym
myofilaments large, polymerized protein molecules; the
major contractile proteins are myosin
(thick filaments) and actin (thin fila-
ments); tropomyosin and troponin, bound
to thin filaments, participate in regu-
lation of muscle contraction. Cross-
bridges project from the myosin filaments
to interact with the actin filaments
myosin filament
has -200 myosin
molecules
length of myosin
filaments: ~1.6u
diameter: ~15-20 nm
myosin m.w. 490,000
G-actin m.w. 4700
neuromuscular
junction
motor nerve ending supplying each muscle
fiber; its branches form a complex of termi-
nals called the end-plate; mitochondria
to make acetylcholine abound in the end-
plate nerve terminals
* Sources: Ganong, 1973; Gray, 1973; Guyton, 1981; Young et al., 1983. Excludes blood
supply and neural network.
2. Energy metabolism in muscle
The energy required for muscular activity is ulti-
mately derived from carbohydrates, whose breakdown is oxidative for
highest muscular efficiency and endurance (Brobeck, 1979), and from
free fatty acids (Ganong, 1973). For brief, intensive activity,
muscle can use energy supplied anaerobically via ATP and creatine
phosphate (CP), and by anaerobic glycolysis, during which the mus-
cle incurs an "oxygen debt".
Excitation-contraction coupling, the process by which the
muscle action potential starts the contraction, derives its energy
from the interaction of ATP with muscle proteins (Young et al. ,
1983). The anaerobic breakdown of ATP and CP yields energy for
muscle contraction, but the stores of ATP and CP in muscle are
sufficient for only a few seconds of sustained maximal muscle con-
traction (Guyton, 1981). However, the aerobic reactions that
follow decarboxylation of pyruvic acid to acetate and its conver-
sion to acetyl coenzyme A yield the greatest amount of energy.
Although the lactate that is formed during anaerobic muscle con-
traction may be used in exercise, its fate is difficult to ascer-
tain, and data on adaptations in the glycolytic enzyme system
consequent to changes in muscle activity are less certain than
for the enzymes involved in end-terminal oxidation (Saltin and
Gollnick, 1983). Small amounts of energy are needed to restore
the regulatory calcium ions from the sarcoplasm to the SR and to
pump sodium and potassium ions through the membranes of the muscle
fibers (Guyton, 1981).
B. ATROPHIC MUSCLE
1. Definition
According to Stewart (1968) atrophy may be considered
as a decrease in size or wasting away of a body tissue or, in growing
organisms, as arrested development. In this report, skeletal mus-
cle atrophy associated with space flight is classed as a type of
"disuse" atrophy, with acknowledgement of the lack of a completely
satisfactory definition of the term. Disuse atrophy is widely used
in the scientific and clinical literature; however, its appropri-
ateness with regard to muscle changes associated with space flight
is questionable.
Abramson (1948) noted difficulties in defining the atrophy
of disuse; he suggested that decrease in size of tissues resulting
from their inability to develop full function might be a general
definition. Robbins and Cotran (1979) list decreased workload as
one of the apparent causes of muscle atrophy, and Saltin and
Gollnick (1983) note that, with disuse or inadequate nutrition,
there is a loss of muscle mass associated with a decrease in cross-
sectional area. The LSRO ad hoc Working Group on Muscle Atrophy
suggested that an acceptable, basic definition might be a reduction
in muscle size or mass in contrast to hypertrophy, with implications
for associated physiologic and functional effects.
Pathophysiologic features of disuse muscle atrophy include
a shrinkage in the size of muscle cells by partial losses of struc-
tural components and organelles such as mitochondria, myofilaments,
and endoplasmic reticulum (Robbins and Cotran, 1979). Atrophic
cells are not dead; eventually, however, with marked degrees of
disuse, muscle cell death may occur, giving way to replacement by
fibrous tissue (Crowley, 1976; Robbins, 1967).
As noted in Section IV, underuse of the skeletal muscula-
ture by space travelers affects mainly the anti-gravity muscles,
is only a partial or relative type of disuse, and has not resulted
in marked degrees of atrophy during space missions lasting up to
6 mo.
2. Causes of muscle atrophy
As mentioned, a decrease or lack of function of
living tissues results in their shrinkage or wasting away (Abram-
son, 1948; Robbins and Cotran, 1979; Stewart, 1968). Atrophy of
muscles of the legs and thighs was reported in human volunteers
kept at strict bed rest while wearing removable lower body plaster
casts for 6-7 wk (Deitrick et al., 1948) and in fracture patients
(Sargeant et al., 1977). Similar effects were reported from other
medium- to long-term bed-rest studies (Buznick and Kamforina,
1973; Kakurin et al., 1966; Krupina et al., 1982; Panov et al.,
1969; Parin et al., 1971; Petukhov and Purakhin, 1971; Rodahl,
1969; Triebwasser, 1968).
Mechanical immobilization of joints leads to weakening
and atrophy of the associated musculature in human subjects
(Danckwardt-Lilliestrom and Sjogren, 1976; MacDougall et al.,
1980; Sargeant et al., 1977; Stillwell et al., 1967; Young et al.,
1980, 1982) and in animals (Booth, 1982; Cooper, 1972; Fournier
et al., 1983; Goldspink, 1977; Herbison et al., 1978; Tabary
et al., 1972; Thomas and Luco, 1944). According to Saltin and
Gollnick (1983), loss of muscle mass associated with joint immobi-
lization results from a decrease in the cross-sectional area of
the muscle.
Muscles of immobilized limbs may decrease in size by 25-50%
in 30 d (Astrom and Adams, 1981; Guyton, 1981). Denervated muscles
undergo rapid atrophy, with a loss in bulk of 70-80% in a period
of 120 d (Astrom and Adams, 1981). Clinical causes of atrophy in-
clude: (1) denervation of the musculature as a result of trauma
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or disease of the spinal cord or motor roots; (2) the spinal muscu-
lar atrophies; (3) the peripheral neuropathies; (4) certain stages
of the progressive muscular dystrophies; (5) the inflammatory myo-
pathies; and, (6) certain myopathies that are associated with meta-
bolic or endocrine disorders (Walton, 1981). Investigative models
for study of disuse atrophy in laboratory animals are, for example,
surgical denervation or pharmacologic block of nerve conduction;
chronic tenotomy, spinal cord transection or isolation, joint immo-
bilization, and suspension of rats to produce a head-down body
tilt with unloading of the hind legs (Fournier et al., 1983; Morey-
Holton and Wronsky, 1981; Musacchia et al., 1980, 1983; Steffen
et al., 1981) (see also p.42). Table 2 lists examples of condi-
tions that result in muscle atrophy.
Interpretation of data on muscle atrophy derived from
observation of patients with fractured, immobilized limbs should
take into account the evolving knowledge of proteolytic factors
that appear to lead to rapid muscle wasting during trauma or sep-
sis (Baracos et al., 1983a; Beisel, 1983; Clowes et al., 1983a).
In this report, primary interest is in the atrophy of the
anti-gravity muscles, whose customary roles in maintaining body
posture on Earth are drastically modified in weightless flight.
This unloading of the musculoskeletal system in zero-G results in
a unique form of disuse. Available data on muscle atrophy associ-
ated with space flight are presented in Sections IV and V.
3. Prevention of muscle atrophy
Except for countermeasures against muscle atrophy in
simulated or actual space flight (see p.18, 35), studies of preven-
tion of disuse atrophy have concerned clinical problems that are
complicated by atrophy, such as those mentioned above.
Reinnervation. Reinnervation of denervated muscle fol-
lowing trauma reverses atrophy and restores physiologic function.
Nerve impairment from trauma varies from transient blockage with-
out disruption of the axon to complete division of the nerve.
When axons are damaged, but supporting connective tissue and the
Schwann cell basement membrane remain intact, regeneration occurs
at 1-2 mm/d. When damage is more severe, but the perineurium and
fascicular structures are preserved, regeneration also takes place,
but less efficiently than in the preceding example (Bradley, 1981).
Surgical correction is required when the damage precludes unas-
sisted nerve regeneration. Thus, if it occurs before atrophy
becomes irreversible, nerve regeneration is an optimum type of
prevention of irreversible muscle atrophy following nerve damage.
Nerve regeneration within 3-4 mo of injury may restore muscle
function fully, whereas reinnervation after two years rarely
restores any muscle function (Guyton, 1981).
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Electrical stimulation. Prevention or retardation of
atrophy of denervated muscle by electrical stimulation has been
demonstrated in the rat (Fischer, 1939; Grodins et al., 1944a,b;
Herbison et al., 1971; Kosman, et al., 1947a,b; Shaffer et al. ,
1954; Stillwell and Wakim 1962; Wehrmacher et al., 1945), the
rabbit (Gutmann and Guttmann, 1944), and the dog (Kosman et al.,
1948). Grodins et al. (1944b) also reported preservation of maxi-
mum tetanic contraction potential by use of a 25 hertz, 6-7 ma
current in denervated gastrocnemius-soleus muscles of dogs. It is
well established that current intensities must be high enough to
produce vigorous muscle contractions to prevent or retard atrophy
in denervated muscles (Fischer, 1939; Herbison et al., 1971;
Wehrmacher et al., 1945).
Opinions vary about the utility of electrostimulation in
treating neuromuscular disorders (Herbison et al., 1971, 1983;
Laughman et al., 1983). In disorders involving motor denervation,
electrostimulation is the only practical means of inducing muscle
contraction (Karpovich, 1968); however, vigorous contraction of
the afflicted musculature in such cases requires current intensi-
ties that exceed the comfort tolerance of the patient. Basic data
appear to be too limited to permit rational scientific understanding
of the effects of electrostimulation on human muscle (Eriksson
et al., 1981; Moreno-Aranda and Seireg, 1981). However, there is
some evidence to support the use of electrostimulation in clinical
situations with muscle atrophy when the motor innvervation is intact
(Eriksson and Haggmark, 1979; Gould et al., 1982, 1983; Romero
et al., 1982). Moreover, data from animal studies (Herbison et al.,
1971) suggest that electrostimulation may prevent or retard atrophy
of denervated muscle. With regard to muscle atrophy resulting
from weightless flight, the opinion of the ad hoc Group as to the
use of electrostimulation is presented in Section V (see p.38).
Ejcercise. Physical exercise by voluntary contraction of
muscle groups has long been used to restore atrophied muscle fol-
lowing injury and disease (DeLorme, 1945). To determine the effec-
tiveness of quadriceps-setting exercises in retarding loss of
strength in fracture patients with immobilized lower extremities,
Stillwell et al. (1967) studied 22 normal subjects and 21 patients
with leg fractures. All 43 persons tested had one lower extremity
in a long leg cast. The exercises consisted of static contraction
of the quadriceps in the casted limbs, held for a count of 10 and
repeated 10 times per hour (exercised patient group) and a single,
6-sec maximal isometric contraction of the quadriceps and hamstrings
four times per day (normal, casted-exercised group). Another con-
trol group consisted of 10 normal subjects who were not in casts
but who exercised isometrically at a knee angle of 120° or 165°.
The normal, exercised subjects in casts maintained pre-casting iso-
metric tension at a knee angle of 120°, maintained 10 repetition
maximum, and increased isometric tension at a knee angle of 165°.
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In the patients, isometric tension and 10 repetition maximum
decreased in both exercised and nonexercised groups; however,
the decline in 10 repetition maximum was smaller in the exercised
patients, suggesting some preventive value in terms of endurance
strength.
Other approaches. Alternative approaches to preventing
or retarding disuse atrophy have been suggested by certain lines
of investigation; for instance, the use of aids to muscle protein
synthesis such as supplemental leucine (Buse and Reid, 1975; Fulks
et al., 1975; Goldberg and Tischler, 1981), substances that reduce
muscle protein degradation in vitro such as leucine and a-ketoiso-
caproate (Goldberg and Tischler, 1981), and substances that reduce
muscle protein degradation in vivo such as mixtures of the branched-
chain amino acids (BCAA) (Stewart et al., 1982). The influence of
anabolic hormones on muscle is also of interest. Goldberg and
Goodman (1969), for example, reported that growth hormone reduced
weight loss and induced growth in denervated muscles in hypophysec-
tomized rats. In another study, restoration of muscle weight,
electrical activity, contractile capacity, and work performance of
the gastrocnemii of immobilized hind limbs of rats treated with
human growth hormone were reported by Apostolakis et al. (1980).
Another possible means for preventing or controlling mus-
cle atrophy involves methods of inhibiting the factors that mediate
muscle proteolysis. For example, cyclooxygenase inhibitors such
as aspirin and indomethacin block muscle proteolysis associated
with the release of interleukin-1 in patients with sepsis or
trauma (Baracos et al., 1983a,b). However, from a clinical point
of view, this appears somewhat controversial (Clowes et al.,
1983a,b; Moldawer et al., 1983); nevertheless, if similar proteo-
lytic factors should be discovered in the search for mechanisms of
disuse atrophy, the concept may have merit. Further elaboration
of the roles of the proteases and their inhibitors found in skele-
tal muscle (Bird et al., 1980) might lead to practical means of
pharmacologic or biochemical intervention. Beneficial effects of
the protease inhibitor, pepstatin, in a mouse model of muscular
dystrophy were reported by Schorr et al. (1978); however, Enomoto
and Bradley (1977) observed no benefit of treatment with pepstatin,
antipain, or leupeptin in mice with heredity muscular dystrophy.
4. Rehabilitation
Experience in rehabilitating atrophic muscles has
been largely in the clinical setting following immobilization of
limbs as a result of injury or disease. The basis of muscular
rehabilitation is voluntary exercise with regimens chosen to suit
individual needs (DeLateur et al., 1968; DeLorme, 1945; Karpovich,
1968; Liberman and Asa, 1959; Miiller, 1970). Restoration of the
musculature to its pre-atrophic bulk and power appears to be
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difficult in many cases and perhaps impossible in some. Stillwell
and colleagues (1967) noted that, with the best available tech-
niques , 3-8 wk were required to restore the quadriceps muscle to
its normal strength, and Karpovich (1968) observed that, often,
definitive treatment ends and rehabilitation starts only after a
long period of time. Discussion by the LSRO ad hoc Group sug-
gested that, in patients recovering from disuse atrophy, young
persons including teenagers, are more likely to recover muscle
bulk than adults, including young adults (see Section V, p.37).
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IV. MUSCLE ATROPHY ASSOCIATED WITH MANNED SPACE FLIGHT
A. NATURE AND OCCURRENCE
In the weightlessness of space flight, the functional load
on the musculoskeletal system is insufficient to maintain normal
physiologic status of the musculature. There is no need for active
opposition to gravity or to maintain customary terrestrial posture,
and the effort required to move the body and its appendages is
remarkably reduced (Pestov and Geratewohl, 1975; Smith, 1978).
Numerous observations of the astronauts and cosmonauts,
of human and animal subjects of ground-based hypokinetic and limb
immobilization studies, and of animals flown in space have demon-
strated skeletal muscle atrophy (Berry, 1973; Cherepakhin and
Pervushin, 1971; Deitrick et al., 1948; Dietlein, 1975, 1977;
Gazenko et al., 1980a; Nicogossian and Parker, 1982; Oganov, 1981;
Pestov and Geratewohl, 1975; Sargeant et al., 1977; Thornton and
Rummel, 1977; Whedon, 1982; Whedon et al., 1977; Whittle, 1979).
Several authors reported postflight decreases in human muscle
volume and mass, particularly in the lower extremities (Pestov
and Geratewohl, 1975), and data from the Skylab series of space
flights showed reduction in muscle strength of the limbs (Thornton
and Rummel, 1977) and confirmed losses of mass of the leg muscles
(Whittle, 1979). Associated effects include decreased muscle
strength and "tone" and reduced work capacity (Pestov and
Geratewohl, 1975). The biomedical results of the Gemini, Apollo,
and Skylab programs included several features in common that were
referable directly or indirectly to skeletal muscle effects: mini-
mal to moderate loss of muscle nitrogen, postflight weight loss,
and postflight decrease in exercise tolerance (Dietlein, 1977).
Oganov et al. (1980) defined the changes in skeletal mus-
cle associated with long-term space flights as "functional atrophy"
and noted that they included loss of muscle mass, decline of mus-
cle "tone", strength, and endurance, primarily of the muscles of
the legs and torso. Increased protein catabolism including break-
down of skeletal muscle has been a consistent finding in space
flight. A reduction of the volume of the lower extremities and a
persistent rise in urinary nitrogen, phosphorus, amino acids, and
3-methylhistidine are some of the typical associated findings
(Nicogossian and Parker, 1982; Whedon et al. , 1977). Whether
these changes are caused by zero-G or other factors in the space
flight environment has not been fully established, but weightless-
ness is generally thought to be the main etiologic factor
(Bricker, 1979; Gazenko et al., 1980b).
In the manned Skylab missions (flight durations were 28,
59, and 84 d), nitrogen and phosphorus balances were negative
during the first 2-3 wk, then negative or slightly positive for
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the remainder of each mission (Rambaut et al., 1979; Whedon et al.,
1977). Total caloric intakes of the nine Skylab crew members
varied from 35.8-49.7 kcal/kg body wt, having been set at 10%
below preflight values for the 28-d mission and 8-10% above pre-
flight levels for the 56- and 84-d missions (Leonard et al., 1983).
Compared with preflight values, five of the crew members decreased,
and four increased their mean caloric intakes during flight. Of
the mean inflight total body weight loss of 2.7 ± 0.3 kg (SD) in
the nine astronauts, more than half was estimated to be from loss
of lean body mass (Leonard et al., 1983).
U.S. astronauts and Soviet cosmonauts have typically
developed negative potassium balance during flight, manifested
postflight by decreased values of serum and urinary potassium,
total body content of potassium-40, and exchangeable potassium
(Gazenko et al., 1980a; Leach and Rambaut, 1977; Leach et al.,
1975). This negative balance has been ascribed to a reduction of
the intracellular potassium depot as a result of a decrease in
cell mass, particularly in skeletal muscle. The negative potas-
sium balance has persisted for as long as 6 d postflight (Gazenko
et al., 1980a).
Changes in strength of the arm and leg extensors and
flexors of each of the three Skylab crews were estimated by pre-
and postflight dynamometry (Thorton and Rummel, 1977). Muscle
strength of the crew of Skylab 2, whose sole inflight exercise de-
vice was the bicycle ergometer, was measured 5 d postflight. Leg
extensor strength was about 25% below preflight levels. Decrements
in arm extensor strength were considerably less than in the legs.
There was no loss in arm extensor strength in the Commander, who
had pedaled the bicycle by hand as well as by leg (Thornton and
Rummel, 1977). In the Skylab 3 mission (59 d) average loss of
strength in the leg flexors was about 18% and about 21% in the leg
extensors. Again, losses of strength in the arm extensors and
flexors were generally less than in the lower extremities, which
probably reflect the relatively greater workload for the arms dur-
ing flight. Thornton and Rummel (1977) noted that the legs receive
virtually no effective loading.
Soviet scientists have stated: "The obvious consequences
of the effects of weightlessness on the motor system included
slight muscle mass losses, visible atrophy of leg muscles, long
and wide back muscles and decrease of muscle tone" (Gazenko et al.,
1981). Kozlovskaya et al. (1981) reported the following muscular
effects in crew members of the 75-, 140-, 175-, and 185-d Salyut
missions: (1) "atony" of the calf muscles rear group and atrophy
of the long muscles of the back; (2) slight "subatrophy" of the
latissimus dorsi muscles; (3) slight decrease in strength of the
gastrocnemius muscles at velocities of 0 and 60°/sec; (4) a notice-
able decrease in strength of the tibialis anticus muscle at all
velocities tested except at 180°/sec; (5) a significant decrease
in strength/velocity relationship of the neck muscles. Apparently
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these decrements in muscle performance capability persisted for
6 or more wk postflight (Kozlovskaya et al., 1981). Magnitude of
the muscle changes bore no clear relationship to flight duration,
but appeared to be inversely proportional to the amount of whole
body exercise done inflight.
Anthropometric measurements of space crews provide addi-
tional data on changes in skeletal muscles during flight. The
range of reduction of leg volume during the Skylab missions aver-
aged from about 7-11% of the preflight values. More than half the
loss in leg volume probably resulted from the cephalad shift of
blood and tissue fluids that accompanies exposure to zero-G; the
remainder is considered a loss of muscle mass (Thornton and Rummel,
1977). Similar results have been reported by the Soviet space
medical scientists (Gazenko et al., 1981). In the long-term
flights, decreases in leg volume were pronounced in the first 3 wk,
then fluctuated between large decreases, periods of stability, and
partial recovery (Nicogossian and Parker, 1982).
Postflight stereometric analysis of the Skylab astronauts
by means of a stereophotogrammetric method showed major losses in
volume of the abdomen, buttocks, and calves, and less pronounced
losses in the thighs (Whittle, 1978; Whittle et al., 1977). From
these studies, Whittle (1979) estimated that eight of the nine
Skylab astronauts probably lost muscle from the legs, the largest
amount being 1.43 kg and the average amount, 0.52 kg.
Finally, integrated electromyograms (IEMG) of the gastroc-
nemius muscles of the crew of Skylab 3 added further evidence sug-
gestive of muscle atrophy (LaFevers et al., 1975). On the first
postflight day, the average predominant IEMG frequency was in the
higher bands compared with preflight measurements. Similar shifts
in the patterns of dominant EMG frequencies have been observed in
patients with nonneurogenic muscular dystrophies (Lenman, 1981),
suggesting that such changes in frequency may characterize muscle
that is undergoing atrophy from nonneurogenic causes. Postflight
IEMG analysis of crew members in long-term Soviet missions showed
more than a two-fold increase in IEMG value of a standard muscular
effort (Nicogossian and Parker, 1982; Yegorov, 1980).
In summary, exposure to weightlessness as well as hypo-
kinesia/hypodynamia, leads to decreases in muscle "tone", strength,
and work (exercise) capacity (Pestov and Geratewohl, 1975). Full
recovery of muscular strength, especially in the legs, following
space flights of medium (weeks) to long (months) duration requires
from several days to several weeks, and data are not available to
show conclusively whether full recovery of muscle bulk takes place.
However, the average leg volumes of the Skylab 3 astronauts reached
preflight values by postflight day 10 (Thornton and Rummel, 1977).
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Studies in the rat. Rats exposed to zero-G in Cosmos bio-
satellites for approximately 20 d showed gross and microscopic and
biochemical evidence of atrophy and a decline of contractile force
and work capacity of such antigravity muscles as the soleus and
triceps brachii (Gazenko et al., 1980b; Oganov, 1981). The data
suggested that an adaptive transformation of the phenotype of the
muscle fibers may occur; for instance, slow, antigravitational so-
leus muscle acquired features of fast muscle. Possible myopathic
effects of the forces of deceleration during reentry and landing
and other possible untoward environmental factors on the ground
prior to recovery were not mentioned (Oganov, 1981). Myofibrillar
and sarcoplasmic proteins were decreased in the soleus, but not in
other muscles examined (Gayevskaya et al., 1976). Muscle glycogen
content and activities of glycogen phosphorylase, adenylate cyclase,
and phosphodiesterase of the space-flown rats did not differ from
controls (Nesterov et al., 1979). Whole muscle demonstrated ac-
celerated rates of contraction (soleus) and a decrease in strength,
elasticity, and endurance (soleus and extensor digitorum longus).
These changes in functional properties were consistent with those
observed in intact space-flown rats; for example, a reduced toler-
ance to static loads (Gazenko et al., 1980b). All observed changes
in the rats' musculature disappeared by the 25th postflight day.
B. COUNTERMEASURES
Most evidence suggests that, despite attempts at interven-
tion such as diet and exercise, skeletal muscle atrophy continues
to some extent throughout orbital flight, manifesting progressive
muscle loss and negative nitrogen balance (Leach et al., 1975;
Nicogossian and Parker, 1982; Rambaut et al., 1975; Whedon, 1978;
Whedon et al., 1977). However, operational experience with the
astronauts and cosmonauts has strongly suggested that vigorous in-
flight physical exercise retards the process of physiologic decon-
ditioning of skeletal muscle as well as the cardiovascular system
(Gazenko et al. , 1981; Nicogossian and Parker, 1982; Thornton,
1981). Therefore, in view of the lack of alternative preventive
methods, daily regimens of physical exercises during flight repre-
sent the primary countermeasure against muscle deconditioning.
Exercise devices facilitate the process; for example, NASA has
developed a compact, teflon-coated panel which can be attached at
an angle to the deck of the spacecraft which, when used with body
tiedowns, simulates a treadmill and permits walking, running, and
even limited jumping. Other exercise devices that have been
developed and used in the U.S. space flights include the bicycle
ergometer and the "MK-I" (modified Mini Gym") and "MK-II" (chest
expander) devices for exercising arms and trunk. NASA scientists
concluded that use of the bicycle ergometer is inadequate for main-
taining leg strength sufficient for normal walking at 1-G post-
flight (Thornton and Rummel, 1977). Comparison of the relative
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degrees of muscle deconditioning of the three Skylab crews sug-
gested that the greater amounts of exercise used in missions 3 and
4 may have accounted for the superior postflight muscular condi-
tion of the Skylab 3 and, particularly, the Skylab 4 crews.
By 1975, the recommended inflight regimen for Soviet
cosmonauts prescribed three exercise periods daily for a total of
2.5 h (Dodge, 1976); more recently, Soviet practice has employed
two 40-min periods daily (Kakurin, 1981). Among the estimated
exercise requirements for inflight use, Thornton (1981) listed:
(1) for preventing or minimizing loss of strength and muscle mass
in the legs, walking and running at an equivalent load of 1-G;
(2) for endurance capacity of the legs, walking for 30 min/d at an
equivalent velocity of 6-7 mph, 5/d/wk. On the bicycle ergometer,
inflight exercises at 80 watt-min/d/kg (4.8 kJ/d/kg) lean body
mass (LBM) (thighs) to 100 watt-min/d/kg (6kJ/d/kg) LBM (calves)
were estimated as the levels of effort required to prevent atrophy
of the thigh and leg muscles (Whittle, 1979). These high levels
of exercise, equivalent to 30-60 min of hard cycling, support the
idea (Thornton and Rummel, 1977) that the bicycle ergometer is
inefficient for maintaining muscle mass and strength.
Current NASA flight schedules include 40 min daily for
exercise. On the other hand, typical Soviet practice in long-term
missions specifies between 1.3 and 2.5 h/d for exercise (Kakurin,
1981; Yegorov, 1981). In the U.S.S.R., attempts are made to
select exercises which involve every muscle group, and they include
use of devices such as a rowing machine, bungee cord exercisers,
a treadmill that permits in-place walking, running, and jumping,
and a bicycle ergometer, all of which are used in each exercise
period.
Other countermeasures. Electrical stimulation of the leg
extensors and possibly other muscle groups is a part of the Soviet
approach to inflight maintenance of muscle. In studies of 18 human
volunteers exposed to head-down bed rest of 5° for 182 d, electric
stimulation of various muscle groups for 10 min/d for 10-15 d re-
portedly was effective as part of a group of methods aimed at pre-
venting or reducing the cardiovascular deconditioning associated
with space flight (Kakurin, 1981). In addition, the cosmonauts
wear an elasticized garment, the "Penguin" suit, which opposes
body movement and, to an extent, compensates for the lack of
gravity on the antigravitational parts of the musculoskeletal
system in the trunk and lower extremities (Gurovskiy et al., 1975;
Nicogossian and Parker, 1982). Electric stimulation and load
suits have not been used operationally by the U.S. astronauts.
In summary, the primary means of intervention upon which
both the U.S. and Soviet space flyers rely for preventing or mini-
mizing muscular deconditioning of space flight is vigorous physical
exercise, mainly of the dynamic type. Operational experience with
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long-term space missions suggests that carefully designed exercise
regimens scrupulously carried out by spacecrews are effective.
However, studies of nitrogen and mineral balances suggest that mus-
cle atrophy continues to progress during exposure to weightlessness
regardless of the use of available countermeasures.
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V. OBSERVATIONS OF THE LSRO AD HOC WORKING GROUP
ON MUSCLE ATROPHY
The meeting of the LSRO ad hoc Working Group on Muscle
Atrophy took place at FASEB Headquarters on July 18 and 19, 1983
(see p.81 for list of participants). The agenda included presen-
tations on NASA's program of research on muscle atrophy by scien-
tists from NASA Headquarters, the Ames Research Center, and the
Johnson Space Center. A wide scope of topics was discussed, with
considerable emphasis on identifying important gaps in knowledge,
research that should be done, the most suitable models for ground-
based and inflight research, and a pressing need for certain
flight-derived data that would be used for validation of ground-
based models and design of meaningful experiments.
A. NATURE, CAUSES, AND MECHANISMS OF MUSCLE ATROPHY
ASSOCIATED WITH SPACE FLIGHT
As noted in Section IV, the skeletal muscle atrophy that
has occurred inflight has apparently not compromised crew function
during missions [except, possibly, during extravehicular activity
(EVA) and lunar surface EVA in Apollo 15 (see below)], nor has it
proved markedly disabling postflight. Nevertheless, recovery of
normal muscular strength, bulk, and exercise tolerance has, in
some cases, required from several days to several weeks. In
missions lasting from about 3 wk to 6 mo, crew members who engaged
in vigorous leg exercises have demonstrated an ability to maintain
inflight aerobic exercise capacity as measured by bicycle ergometry,
However, a postflight decrement in muscle strength and endurance
has been universally observed, albeit to varying degrees.
Few instances have been reported of spacecrew exposure to
extraordinary muscular demands during long-term missions, such as
strenuous EVA, in which high muscular efficiency may be at a pre-
mium. However, high heart rates accompanied EVA during the Gemini,
Apollo, and Skylab missions. For example, peak rates exceeded 160
beats/min in four of the Gemini EVA experiences (Nicogossian and
Parker, 1982). During the lunar surface activities, two of the
Apollo 15 crew developed cardiac arrhythmias and extreme fatigue;
the arrhythmias recurred during the return flight to Earth (Berry,
1974; Pestov and Geratewohl, 1975). Postflight, the Apollo 15
crew demonstrated potassium deficiency and had marked difficulty
in readjusting 1-G (Berry, 1974). Two years after the mission one
of the crew who had cardiac arrhythmias during the mission suffered
a myocardial infarction (Nicogossian and Parker, 1982). Berry
(1974) noted that, compared with the other Apollo missions, the
foregoing untoward responses appeared to be an anomaly.
Skeletal muscle atrophy was one of several adaptive re-
sponses, such as cardiovascular deconditioning, that probably con-
tributed to the tachycardia, arrhythmia, and fatigue mentioned
21
above. It is noteworthy that EVA is scheduled in several of the
Space Shuttle missions. In view of the fact that crew effective-
ness has apparently not been compromised significantly by the
muscle atrophy, one might conclude that it is of no practical con-
sequence. However, this position would be fundamentally inconsis-
tent with good preventive medical care of space flyers, the goal
of which is to take all necessary precautions against any adaptive
responses to space flight unless they are shown to be beneficial;
that is, to stop the changes before they occur so that weightless-
ness can be written off as a harmful influence. Thus, muscle
atrophy is a significant biomedical problem of space flight. It
justifies sufficient investigative effort to determine the exact
causes and mechanisms involved, and, ultimately, some practical,
efficient means of prevention or control that will cause minimum
interference with the astronauts' demanding schedules before,
during, and after space missions.
Opinions of the ad hoc Group varied on the question of
full recovery of atrophic muscle following space flight. Some par-
ticipants were convinced the atrophy is fully reversible; others,
based on clinical experience with patients following limb immobili-
zation and other data (Danckwardt-Lilliestrom and Sjogren, 1976;
Salter, 1957), believed that full recovery of preflight muscle
bulk may not occur; however, full recovery of muscle strength and
endurance is likely. There have been reports of persistent decre-
ments in strength and coordination in such activities as tennis in
cosmonauts following long-term missions, but no quantitative data
are available.
1. Causes of muscle atrophy in space flight
Opinions of the ad hoc Group varied as to the prob-
able cause(s) of muscle atrophy in space flight. Of the several
prevalent environmental influences such as weightlessness and the
relative hypodynamia and hypokinesia imposed by the spacecraft
dimensions and types of crew activities, all agreed that the un-
loading of the antigravity parts of the musculoskeletal system is
the primary cause. Again, at the level of the whole organism, a
majority believed the lack of production of customary muscular
force is a key causal factor. Probably related to this are clini-
cal observations that a stimulus for muscle growth is pull across
the corresponding joints. Production of muscle force-velocity in
space probably requires activation of fewer motor units than are
needed for the same level of contraction on Earth. In ground-
based studies, care should be taken to simulate the force-velocity
parameters that prevail in space flight, a factor that emphasizes
the need to acquire more data of this sort from astronauts inflight
However, there was some reluctance to accept lack of pro-
duction of muscle force as an etiologic factor in the absence of
data on mechanisms of "nonexercise" atrophy and of exercise hyper-
trophy. Additional factors such as hormonal imbalance may be
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involved although it is known that muscle growth occurs both in
the skeletal muscle in response to extirpation of a synergist
(Goldberg, 1967) and cardiac muscle in response to a pressure
overload (Tipton and Tcheng, 1971) in hypophysectomized rats.
An important question related to muscle atrophy that NASA
should answer is: What events occur or do not occur in a space
environment that do or do not occur at 1-G that could cause muscle
atrophy? (Table 3).
Table 3. Comparison of Some Macro-Level Events in Space and on
Earth That May Be Important Factors in Inducing Muscle Atrophy
Response* Earth Space
EMG ++++ +++
Force ++++ +
Velocity +++ ++++t
Metabolic ++++ +++§
Neurohormonal +++ ++++
* normal or optimum = ++++; minimal = +
t assumed to increase until subject adapts to zero-G
§ hypothetically, fewer muscle fibers are activated for limb and
body movements in zero-G
Practical approaches are available for defining the prob-
lem of muscle atrophy in astronauts. For example, when muscles
are activated, varying force and velocity combinations are produced
by each muscle and muscle group. With very minor adaptations of
existing technology, muscle activation (electromyography), forces
(strain gauges) and velocities (video or potentiometers) can be
monitored in astronauts on Earth and during space flight. For
example, electrogoniometers and software are commercially available
which record in three planes and are lightweight and easily adapt-
able for use in spacecraft. The foregoing measurements should,
and can, be done at least intermittently over a 24-h period. This
information probably will provide the answer to the critical ques-
tion posed above. Such a direct approach, with both human and ani-
mal subjects, probably offers the best likelihood of yielding
practical data leading to: (1) an understanding of the cause(s)
of space-related muscle atrophy; (2) identifying the best ground-
based models for study; and, (3) designing more meaningful experi-
ments and countermeasures (see also, Research suggestions, p.30-31),
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2. Mechanisms
It is generally acknowledged that the exact biologic
mechanisms that induce muscle atrophy are unknown and that this is
true of muscle hypertrophy also. Approaches to investigation are
suggested by certain established principles of muscle biology and
some of the known biologic responses in models of disuse atrophy,
examples of which include the following:
• Decreased rates of muscle protein synthesis, appearing
within 6 h in immobilized rat limbs (Booth, 1982) return
to normal rates within 6 h after remobilization (Booth
et al., 1982).
• Insulin responsiveness for 2-deoxyglucose uptake at the
24th hour decreases in the same model (Booth, 1982;
Seider et al., 1982).
• Insulin appears to be an important hormonal factor for
short-term regulation and maintenance of positive protein
balance in skeletal muscle (Goldberg et al., 1980a).
• Possible retrograde influences of muscle may affect motor
nerves (Booth, 1982).
• Marked differences occur in rates of atrophy of stretched
immobilized muscle versus muscle immobilized in the
resting or shortened positions (Booth, 1977, 1982; Simard
et al., 1982; Specter et al., 1982; Thomas and Luco,
1944).
• An intact, functioning nerve supply is necessary to
maintain skeletal muscle in a normal physiologic state
(Guyton, 1981). When muscle is denervated, strong
electrical stimulation may retard atrophy (Karpovich,
1968).
• In vivo, sarcolemmal resting membrane potentials have
been shown to decrease in denervated muscles (Stanley
and Drachman, 1980) and, in muscles of immobilized limbs,
to decrease (Mills et al., 1978) or to remain unchanged
(Fischbach and Robbins, 1971; Goldberg et al. , 1980b).
• Elevated blood cortisone levels have been reported during
limb immobilization (Ganong et al., 1955) and space flight
(Leach and Rambaut, 1977).
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• Alkaline serine proteinases such as those present in mast
cells have not been found in muscle cells; however, their
tissue concentrations increase dramatically in the muscu-
lar dystrophies, starvation, and endocrine imbalances
(Bird et al., 1980). Their possible role in conditions
that feature accelerated degradation of myofibrillar pro-
teins may deserve further study.
• Intracellular Ca^+-activated proteinases may offer ap-
proaches to investigating the regulation of muscle pro-
tein turnover (Dayton et al., 1976; Reddy et al., 1975).
• Cathepsins B, D, H, and L and associated inhibitors such
as pepstatin and leupeptin may be involved in myofibrillar
protein degradation of disuse atrophy (Bird et al.,
1980).
• An apparent increase has been reported in glucocorticoid
receptors in the cytosol of immobilized gastrocnemius
muscle cells (DuBois and Almon, 1980).
• The somatomedins stimulate both proliferation and dif-
ferentiation of muscle cells in vitro. Insulin is active
only at grossly supraphysiological concentrations, and
probably cross-reacts with the somatomedin receptors
(Ewton and Florini, 1981).
• Passive tension or repetitive stimulation retards protein
degradation in isolated muscle preparations (Goldberg,
1979; Goldberg et al., 1975).
• Muscle protein degradation may be induced by thyroid hor-
mones (Goldberg et al., 1980a). Increased postflight
levels of thyroxine in the Apollo (Sheinfeld et al., 1975)
and Skylab (Leach and Rambaut, 1977) astronauts, suggest
heightened thyroid gland activity during missions.
• Intracellular leucine concentrations may influence the
rate of protein synthesis in disused muscle (Morgan
et al., 1981).
• Inactivity of skeletal muscle induced by joint immobili-
zation or by pharmacologic or surgical denervation is
associated with an increase in extrajunctional acetyl-
choline receptors (Fischbach and Robbins, 1971; Lavoie
et al., 1976; Pestronk et al., 1976a).
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B. SELECTED PHYSIOLOGIC FACTORS
1. Nutrition
The essential importance of adequate nutrition for
the maintenance of positive nitrogen balance is well recognized.
Consequently, a great deal of care goes into the provision of well-
designed meals that offer ample amounts of calories and all the
macro- and micronutrients in accordance with modern nutritional
practice. Data from the U.S. and Soviet manned space program were
discussed by the ad hoc Group. Reports of Soviet missions lasting
up to 6 mo (Gazenko et al., 1981; Yegorov, 1981) suggest that the
cosmonauts were able to maintain their body weight with the diets
provided and the daily schedule of activities including physical
exercise. Metabolic studies carried out in the Skylab program led
to a conclusion that, despite the provision of well balanced, care-
fully formulated diets, the astronauts experienced a net negative
nitrogen balance, part of which has been ascribed to loss of mus-
cle mass. Although adequate nutrition is provided for spacecrews,
the meals are not always taken systematically or consumed com-
pletely, especially during the first few days of a space mission.
However, in the opinion of the ad hoc Group, and with the assump-
tion that the astronauts consumed adequate food during past space
flights, nutrition was not considered to have been a significant
factor in the etiology of muscle atrophy. Consequently, additional
nutritional intervention, with the possible exception of the BCAA,
was not considered a promising investigative approach to the prob-
lem of muscle atrophy. However, the possibility that supplemental
BCAA or their alpha keto analogues might benefit synthesis of mus-
cle protein deserves consideration (Goldberg and Chang, 1978;
Goldberg and Tischler, 1981; Morgan et al., 1981; Stewart et al.,
1982). In addition, for maintenance of optimal muscular strength
and endurance, a well-balanced diet is essential.
2. Metabolic changes
The mineral and nitrogen metabolic study of the
Skylab astronauts, known as Experiment M 071 (Rambaut et al.,
1977, 1979; Whedon et al., 1977), was carefully planned and car-
ried out. It involved critical efforts of the investigators and
extraordinary cooperation of the astronauts to maintain constant
dietary intake and continuous daily urine and feces collection for
periods spanning 3-4 wk preflight, continuously inflight, and
finally, about 2.5 wk postflight.
Discussion of the results of Experiment M 071 suggested
that, despite its excellence, certain shortcomings in specimen
collection and analysis may have led to overestimation of the
reported, inflight, negative nitrogen balance. The nitrogen excre-
tion rates reported were high, much higher than those reported from
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human bed-rest studies. Nevertheless, the available data seem to
indicate that the nitrogen balance of the Skylab astronauts during
the space flights varied from negative to only slightly positive.
In addition, other evidence from the Skylab biomedical studies,
such as a negative shift in potassium and phosphorus balances,
points toward degradation of skeletal muscle as the main source
of the negative or marginal nitrogen balances (Leach and Rambaut,
1977; Thornton and Rummel, 1977; Whedon et al., 1977; Whittle
et al., 1977). Total hydroxylysine excretion also increased,
suggesting breakdown of collagen (Leach and Rambaut, 1977).
Soviet scientists have reported that the inflight physi-
cal fitness and nutritional measures used in their long-term mis-
sions have succeeded in preventing undue muscle atrophy and have
preserved body weight (Gazenko et al., 1981; Yegorov, 1981). How-
ever, maintenance of the cosmonauts' body weight may have been, in
part, at the expense of muscle mass. Soviet investigators have
reported decreases in blood levels of free amino acids postflight
in the crews of Salyut missions lasting 21-, 140-, and 185-d
(Popov and Latskevich, 1983a,b,c). As a result, cosmonauts' diets
have been supplemented with amino acids.
In light of the available information, the ad hoc Group
considered that a negative nitrogen balance and some degree of mus-
cle atrophy occur in weightless flight, but that it is possible to
retard the muscle deconditioning by exercise regimens that have
already been demonstrated inflight. In contemplating the gross
dimensions of muscle atrophy, it is useful to recall that muscle
is 20% protein; thus, for example, loss of 300 g muscle protein
would represent a loss of 1.5 kg of muscle tissue.
3. Neurophysiologic and kinesiologic aspects
Considerable discussion was devoted to neurologic
and neuromuscular aspects of disuse muscle atrophy such as myo-
neural junction physiology, neurotrophic factors, motor unit
recruitment, and various means of manipulating the motor innerva-
tion of muscle to produce study models including models of disuse
atrophy. The latter are treated in Section V-E (p.41).
Some of the key questions pertaining to neuromuscular
function in relation to space flight include: (1) What level of
activation of muscles and what forces, and perhaps velocities of
movement occur in a normal day's activities of an astronaut on
Earth and in space? (2) What is the level of neuromuscular poten-
tial output prior to, during, and after space flight? (3) Is the
neuromuscular fatigability of astronauts affected during space
flight? The atrophy that occurs during space travel is almost
certainly muscle mass lost in cross-sectional area and not in the
length of fibers as can occur in some immobilization studies. So,
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changes in muscle force may reflect changes in the degree of
atrophy. Another possibility, however, is that during prolonged
flight there will also be a change in the maximum level of neuro-
muscular excitation that an astronaut can produce. The strength
test is the best test for this in that it is functional, simple,
and can be performed easily. If atrophy occurs without a loss
in strength, then this too would be useful information. The EMG
signal will provide information relative to the level of excita-
tion of the muscle group being tested.
A good deal of experimental evidence supports the view
that one of the key neurotrophic factors influencing muscle func-
tion and integrity is the neuromuscular transmitter, acetylcholine
(Ach), and its associated regulatory processes at the myoneural
junction (Drachman, 1974; Drachman et al., 1982a,b). Pharmaco-
logic blockade of Ach transmission changes the resting membrane
potential (RMP) and the number of extrajunctional Ach receptors in
skeletal muscle in a manner quantitatively equal to that of surgi-
cal denervation (Drachman et al., 1982a,b), suggesting to the
investigators that Ach transmission is the neurotrophic factor
that regulates the two properties studied. In addition, the data
suggest that spontaneous, nonquantal Ach release may regulate
other properties of skeletal muscle that have been ascribed to non-
impulse-mediated, "forward" neurotrophic factors such as substances
delivered to muscle via axonal transport in motor neurons (Guth
and Albuquerque, 1977; Guth et al., 1981; Gutmann, 1975, 1976).
Members of the ad hoc Group noted that, while the term
"trophic" has acquired different meanings in various branches of
biologic science, fundamentally it means nutritional, and the ety-
mology of neurotrophic should indicate whatever the motor nerve
does to maintain the integrity of the muscle. According to Gutmann
(1976) the term "neurotrophic relations and functions" should be
restricted to long-term regulation not mediated by nerve impulses.
The question whether such nonimpulse, forward neurotrophic factors
are involved in skeletal muscle maintenance has been debated for
decades and remains unresolved. The ad hoc Group's opinion on
this was divided; however, the question appears to have little
relevance to the etiology of space-related muscle atrophy where
the nerve supply remains intact. Nevertheless, it is important in
terms of the types of animal models that should be used in the
study of disuse atrophy.
Another question concerns the effect of hypokinesia, hypo-
dynamia, and limb immobilization on neural activation of muscle.
There are only a few published reports in which the quantity of
neuromuscular electrical activity has been measured in muscles of
immobilized limbs over, for instance, a 24-h period (Fischbach and
Robbins, 1971; Fournier et al., 1983). Integrated EMG values were
remarkably decreased in some experiments, but not abolished, and
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inter-study variation in values was substantial. Fischbach and
Bobbins (1971) reported no changes in junctional sensitivity to
Ach and muscle membrane sensitivity in their immobilized rat model,
and they considered it unlikely that any form of immobilization in
which the innervation remains intact would result in complete syn-
aptic silence. However, the significance of sustained neuromuscular
electrical activity in immobilized limbs in terms of muscle atrophy
is not clear.
Finally, it was noted that motor nerve denervation does
not always result in muscle atrophy. Examples are hypertrophy of
denervated diaphragm and anterior latissimus dorsi muscles of
chickens (Feng et al., 1962, 1963; Sola and Martin, 1953; Sola
et al., 1973). Reasons for the apparent paradox are not known,
but muscle stretch was suggested as a possible mechanism.
4. Endocrine changes
With respect to the significance of the hormonal
changes that have been reported from manned space flight, the
degree of change, as reflected by plasma and urine levels, was
probably insufficient to influence muscle integrity and function.
This opinion was based on evidence from both animal experiments
and clinical experience with endocrinological disorders suggesting
that substantial deviations from normal levels of circulating hor-
mones are needed to cause muscle wasting. On the other hand, some
participants believed that further investigation of hormonal inter-
actions with skeletal muscle is justified in attempting to advance
the quest for mechanisms of muscle growth, hypertrophy, and atro-
phy as well as metabolic regulation. Although it seems unlikely
that alterations in growth hormone and/or somatomedin levels
during space flight would cause disuse atrophy, it is possible
that these hormones (or agents that cause their secretion) could
be very useful in the treatment of the condition.
In addition, data from experiments with a rat model of
hypokinesia (head-down suspension) showed significant changes in
glucocorticoid levels and density of glucocorticoid receptors in
hindlimb muscles, which were consistent with increased muscle pro-
tein degradation (DuBois and Almon, 1980, 1981; Steffan and
Musacchia, 1982). However, one member of the ad hoc Group empha-
sized that circulating hormone levels, not tissue receptor levels,
usually determine the level of a tissue response.
The animal castration model (Hanzlikova and Gutmann, 1978)
was not considered appropriate for studies of space-related muscle
atrophy. Finally, the question whether there is a significant cen-
tral hormonal effect on muscle atrophy associated with disuse or
weightlessness appears unresolved.
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5. Research suggestions
Experiments should be planned to test the effects of
dietary supplements of the BCAA, particularly leucine, and the
keto-analogues of the BCAA in both ground-based and space-flown
animal models of disuse atrophy.
In view of the limited knowledge about the rates of loss
of nitrogen during space flight, consideration should be given to
undertaking additional human metabolic studies in suitable future
space missions. Useful data could be derived from such an experi-
ment in the Shuttle program; however, more meaningful data would
require longer-term missions such as those contemplated for the
space station.
To obtain data on the neuromuscular activity during an
astronaut's typical day, terrestrial as well as inflight measure-
ments are needed. These should include: (1) electromyography,
with surface electrodes, of the quadriceps and hamstrings as well
as the dorsi- and plantarflexers of the feet; (2) forces produced
on the heel and bases of the metatarsals via transducers built
into the footwear; and, (3) joint movements by means of sensors on
the knee and ankle. Each parameter can be recorded directly on
small units similar to those used for ambulatory electrocardi-
ography. Techniques are available for all the suggested measure-
ments; however, some equipment development may be necessary for
item (2).
It would appear that these devices can be integrated
without any infringement on the existing planned programs. There
should be no significant effects on the astronauts. They should
not have to modify their planned programs and there should be
little or no discomfort to them. The experiment is simply to
determine what they do with respect to movement during their nor-
mal activities. It will require no additional time inflight or
preflight once the appropriate sensors are instrumented.
For acquiring human data on the level of neuromuscular
potential output prior to, during, and after space flight, the
following is suggested: measure the maximum force that can be
produced at zero velocity for the knee extensors, knee flexors,
and the dorsiflexers and plantarflexers of the feet. The neces-
sary tension-recording device can be installed into the existing
hardware of the spacecraft. The strain gauge could weigh only a
few milligrams. The same device used for recording EMGs could be
used for these maximum force data.
A more nearly functional assessment of neuromuscular
activity would be to test the ability to exert a maximum force at
some selected velocity, or better, to produce some target force at
some target velocity. This is technically within the state-of-the-
art, but would require more development for inflight use than the
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previously mentioned test. It would also require some time commit-
ment from the astronauts. These tests would not be useful in
detecting muscle atrophy, but they would determine whether there
is a functional change in movement control that might occur as a
result of muscle atrophy. This information would be very important
because of the fine movement control that is presumably needed in
routine operations during flight.
To investigate the question of neuromuscular fatigability
during space flight, measure the maximum force that can be produced
over a period of 2 min while exerting a maximal effort once every
second, with simultaneous recording of the EMG. This test should
be done several times preflight, within a week of launch, and as
soon after return as possible (within Id). The muscle group to
be tested initially should be perhaps the plantarflexers of the
foot. The recording devices could be the same as in the previ-
ously described experiment. Other muscle groups should be tested
eventually, e.g., dorsiflexers of the foot and elbow flexors and
extensors. Also, if an arm exercise is being performed, some ven-
ous blood samples could provide an indication of significant
changes in the metabolic potential of the muscle group. This
experiment is important because there is the general idea that dis-
use results in a rapid, significant loss of a muscle's metabolic
potential.
Three properties of skeletal muscle that should be con-
sidered for study in the rat model of hypokinesia (e.g., the tail-
suspension model) are RMP, extrajunctional Ach receptors, and
isometric muscle strength. Additional studies are needed to deter-
mine whether the decrease in IEMG activity reported from experiments
on immobilized limbs (Fischbach and Robbins, 1969; Fournier et al.,
1983) influences the degree of associated muscle atrophy.
Consideration should be given to the extension of studies
such as those of Florini and associates (e.g., Ewton and Florini,
1981) and Almon et al. (e.g., DuBois and Almon, 1980; 1981) to
include the effects on mature muscle cells, isolated muscle prepa-
rations, and intact muscles in vivo, of altered levels of hormones
and possible changes in their receptors that are known to result
from various models of hypokinesia and hypodynamia including
actual weightlessness (e.g., Tigranyan et al. , 1982). Studies are
needed, as well, on the influence of growth hormone and the somato-
medins (e.g. . Florini et al., 1977; Goldberg and Goodman, 1969)
and anabolic steroids (Powers and Florini, 1975) on muscle protein
synthesis and muscle atrophy in animal models of hypokinesia/hypo-
dynamia. However, these studies should be designed with full
awareness of the whole animal studies done by Florini's group in
the 1960s.
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C. BIOCHEMICAL ASPECTS
Discussion involved mainly the loss of myofibrillar pro-
tein, regulation of protein synthesis and degradation, alterations
in metabolic potential, and associated enzymatic changes in muscle
atrophy induced by hypokinesia/hypodynamia.
The main problem in understanding muscle atrophy is that
some basic questions concerning muscle biology still remain unan-
swered. For instance, although a wealth of information exists
about the biochemistry of protein synthesis, the basic mechanisms
of muscle protein synthesis and degradation in biologic responses
such as muscle atrophy and hypertrophy are not well understood
(Millward et al., 1980a,b). Conceivably, decreased rates of pro-
tein synthesis might reflect specific adaptations to altered
energy demands rather than to disuse, per se; however, the availa-
bility of energy does not appear to be rate-limiting in protein
synthesis (see p.33). Muscle protein degradation was reviewed
recently by Millward et al. (1980a). It has been demonstrated
that a portion of the cellular protein is degraded within lyso-
somes (Goldberg and Chang, 1978), and to some extent this portion
of protein degradation is sensitive to growth factors such as
insulin. However, this association is not sufficient to implicate
the lysosome in the degradation of normal actin and myosin or in
the accelerated degradation seen in disuse atrophy. Little is
known about the mechanism of disassembly and degradation of the
contractile apparatus. It is equally possible that the lysosome
is involved in the degradation of membrane receptors and certain
macromolecules which require hydrolytic action to release specific
precursors or cofactors and not contractile proteins (Stauber
et al., 1981).
Two examples illustrate such an alternative role for the
lysosome in muscle metabolism. The first and best known is the
uptake and degradation of low density lipoproteins (LDL) by receptor-
mediated endocytosis. Here LDL are delivered to lysosomes where
the protein is degraded to amino acids and the cholesteryl esters
to free cholesterol to be used by the cell for synthesis. The
second is the transport of cobalamin (vitamin 8^ 2) via a protein
carrier, transcobalamin II. Again the lysosome is utilized to
digest the carrier to release the active cofactor. Thus, it is
desirable to investigate the role of lysosomes in muscle metabolism,
but from a broad point of view. Considerable cytochemical informa-
tion on lysosomes in muscle is available that is pertinent to pro-
teolytic enzymes, pathways, and regulatory mechanisms of protein
degradation during disuse atrophy (Trout et al., 1979a,b; 1981),
but it has not helped to explain a possible role of lysosomes in
muscle atrophy. Two alkaline proteases have recently been identi-
fied in muscle, and their possible role in activation of lysosomal
proteases has been demonstrated (Stauber et al., 1983). It is
likely that the list of proteases in or associated with muscle
will continue to expand.
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Technical problems in the measurement of rates of protein
degradation in skeletal muscle have impeded progress in this area
(Goldberg and Dice, 1974; Goldberg et al., 1980a). Consequently,
data on muscle protein turnover should be interpreted with caution,
particularly in terms of quantitative changes. For instance, it
may be premature to reach firm conclusions on muscle protein syn-
thesis and degradation from experiments involving prelabeling of
muscle and measuring release of phenylalanine in a model of hypo-
kinesia. Nevertheless, it is generally accepted that there is a
loss of myofibrillar protein in muscle atrophy, with a reduction
in cross-sectional area of the muscle fibers and a change in meta-
bolic potential. A fundamental problem is the lack of an identi-
fied mechanism for explaining exercise hypertrophy in muscle, that
is, to bridge the gap between increased turnover of ATP to increased
muscle protein synthesis. An important research goal is to iso-
late the substance in exercising muscle which stimulates synthesis
of the myofibrillar proteins (Saltin and Gollnick, 1983). Such a
discovery could lead to more precise experiments on the mechanisms
of muscle atrophy induced by inactivity.
1. Metabolic capacity
Much information has been generated in recent years
about the adaptability of skeletal muscle to various modes of use
and under-use (Saltin and Gollnick, 1983). Numerous studies in
rats and other species have shown that endurance training increases
the capacity of the citric acid cycle, fat oxidation, and the
electron-transport system. However, data on the effect of inactiv-
ity on the metabolic capacity of muscle are relatively limited.
Joint immobilization in experimental animals has been shown to reduce
the oxidative capacity of muscle, but to a lesser degree than inac-
tivity produced by denervation (Saltin and Gollnick, 1983). For
example, changes in muscle cell mitochondria reflected by reduced
capacities to oxidize glucose, pyruvate, palmitate, and 8-hydroxy-
butyrate have been reported in a rat model of disuse (Rifenberick
and Max, 1974; Rifenberick et al., 1973). On the other hand,
relatively small changes in metabolic capacity have been reported
after prolonged immobilization of primate hindlimbs (Edgerton
et al., 1975). From their recent literature review, Saltin and
Gollnick (1983) noted a general concensus that there are no major
changes in the contractile characteristics of skeletal muscle as a
result of various types of physical training or inactivity.
It is known that in normal skeletal muscle, about 99% of
the ATP that is hydrolyzed is used for contraction; large changes
in the amount of available energy in the cell occur without affect-
ing nucleic acid synthesis. Moreover, there is no evidence that
the availability of energy is rate-limiting in protein synthesis.
However, the effects of genetic regulation are relatively well
established, and are rate-limiting in situations in which plenty
of energy is supplied. This appears to be a promising area of
investigation.
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The lowering effect of inactivity on mitochondria! size
and numbers and on the aerobic capacity of muscle has been shown
in studies that demonstrated a close correlation among these prop-
erties and levels of muscle activity. For example, Saltin and
Gollnick (1983) cite 32 reports from studies in the 1960s and early
1970s of adaptations of mitochondrial enzymes of human skeletal
muscle in response to endurance training. The largest increases
in muscle mitochondria occur in response to submaximal, prolonged
exercise where lactate levels rarely rise very high. However,
with heavy resistance exercise, high lactate levels are produced
and muscles increase in mass, but not in numbers of mitochondria.
In immobilized limbs of rats, loss of respiratory control and
malate dehydrogenase activity in the gastrocnemius and plantaris
muscles promptly followed skeletal fixation and there was a reduc-
tion in the yield of mitochondrial protein throughout the course
of atrophy (Rifenberick et al., 1973). Energy metabolism in the
same model decreased in the atrophying muscles (Rifenberick and
Max, 1974), suggesting to the investigators that deficiencies in
energy metabolism may be significant in the progression of muscle
atrophy.
It is known that, following limb injuries, athletes can
restore muscle strength in the affected limb within about 30 d;
however, return of muscle endurance may require 6 mo or longer
(Sherman et al., 1981). Measurement of mitochondrial enzyme
markers was suggested as an approach to following the responses
of muscle to reduced activity such as in space flight. However,
some participants considered that the mitochondrial response to
inactivity may be either unrelated to or too variable to provide a
firm basis for estimating muscle atrophy. For instance, in cross-
reinnervation/innervation experiments in cats, there was no muscle
atrophy and the mean tension of motor units in the cross-reinner-
vated and reinnervated muscles was normal (Chen et al., 1982). In
addition, the slow-oxidative, fatigue-resistant muscle maintained
a high oxidative capacity as was shown histochemically, and a
resistance to fatigue even though the muscle was reinnervated by
fast, low-oxidative, and fatigable motoneurons (Edgerton et al.,
1980). Thus, some members of the ad hoc Group believed the sig-
nificance of mitochondrial change in relation to the atrophic
process has not been firmly established.
2. Research suggestions
In the search for mechanisms of muscle atrophy
resulting from inactivity or under-use, studies of mechanisms of
exercise-induced hypertrophy should be considered. Key targets in
such investigations include identification of the specific stimuli
generated by exercise and determination of how such stimuli are
communicated as specific chemical signals to the genes to induce
the synthesis of proteins involved in muscle hypertrophy. For
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example, a major breakthrough would be to isolate a protein or
other agent which is secreted by, or found in, exercising muscle,
which stimulates the reading of the DNA of actin and myosin.
Investigations of the effects of inactivity or under-use
of skeletal muscle on the synthesis and degradation of muscle pro-
teins need to be rigorously controlled in order to yield useful
quantitative data. Results of some experiments appear question-
able because of uncontrolled variables such as reutilization of
amino acids of degraded muscle proteins and lack of data on rates
of synthesis and degradation in the models used.
D. COUNTERMEASURES
Discussion of methods of intervention to prevent or con-
trol muscle atrophy associated with space flight focused on physi-
cal exercise, nutrition, pharmacologic or biochemical approaches,
and electrostimulation. Rehabilitation of atrophic muscles was
discussed also, although it was recognized that NASA's objective
is to obviate the need for rehabilitation by prevention or control
of muscle atrophy.
1. Exercise
Available data seem to indicate that daily, vigorous
physical exercise inflight such as can be done with the aid of
various devices (see p.18) retards the rate and degree of muscle
atrophy during long-term missions (Gazenko et al., 1981; Nicogossian
and Parker, 1982; Thornton and Rummel, 1977). However, the avail-
able evidence of a continuing negative or marginal nitrogen bal-
ance (Leach and Rambaut, 1977; Whedon et al., 1977) as well as the
disproportionate amount of time devoted to exercise, such as the
1.3-2.5 h/d prescribed for Soviet missions, emphasizes the need
for improvement in methods of intervention. Thus, further inves-
tigations are indicated to determine types and amounts of physical
exercise that would help to preserve muscle strength, endurance,
and mass with the least daily expenditure of time and energy. The
literature is enormous on exercise and work physiology, physical
fitness training, strength and endurance training, and muscle
rehabilitation following injury or disease. However, the limited
data on the effects of space flight on muscle strength and endur-
ance suggest a need for additional information that can be obtained
from inflight experiments (see p.30, 31), and ground-based simula-
tion studies. Even without additional data, expert analysis of
available knowledge should permit some improvement in recommended
types and amounts of exercise by judicious selection of methods
between the known extremes of one daily isometric contraction of
one second's duration at two-thirds of maximum strength to main-
tain strength (Hettinger and Miiller, 1953) and the 1.3-2.5 h/d
combination of exercises used by the cosmonauts.
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One possible reason suggested for the apparent utility of
the treadmill-type device as an aid to inflight exercise is that
it includes eccentric contractions, that is, the lengthening of
muscle while it is developing tension (Seliger et al., 1980).
According to unpublished information presented during the ad hoc
meeting, recent clinical experience has shown that pure eccentric
exercises used following hand surgery resulted in dramatic reha-
bilitation. It has also been shown that creatine kinase (CPK) is
released to a far greater degree during eccentric than concentric
contractions (Newham et al., 1983a). However, it appears that
muscle damage and muscle soreness are more likely with eccentric
than with other forms of exercise (Hikida et al., 1983; Newham
et al., 1983b). Since the question whether eccentric contraction
is superior to concentric modes for rehabilitation and strength
training and for retarding muscle atrophy in models of inactivity
has not been settled, it deserves additional study.
The matter of preflight, optimal physical fitness for
withstanding the adverse effects of weightless flight appears to
be unresolved. In terms of resistance to certain effects of mus-
cle atrophy, some evidence suggests that physical training before
experimental immobilization provides a "reserve" of neuromuscular
function that retards loss of voluntary strength and reflex poten-
tiation, compared with untrained control subjects (Sale et al.,
1982). It has been customary, incidentally, for space flyers to
keep themselves in a high state of preflight physical fitness.
However, some investigators believe that a high level of preflight
fitness based, for example, on endurance training, tends to
increase susceptibility to orthostatic intolerance postflight
(Klein et al., 1977). These investigators suggested postflight
orthostatic tolerance depends, in part, on the size of the vascu-
lar bed in the leg muscles, which is known to decrease in atrophic
muscle. Thus, the hypertrophy of muscle which results from some
types of physical training would appear to be a disadvantage
during the immediate postflight period (Whittle, 1978).
It has long been known that immobilizing a muscle in a
stretched mode will markedly retard the rate of disuse atrophy for
a limited number of days or weeks (Booth, 1977, 1982; Summers and
Hines, 1951; Thomas and Luco, 1944; Thompson, 1934). Moreover,
stretch-induced hypertrophy of skeletal muscle has been reported
in animal models such as the chicken (Holly et al., 1980; Sola
et al., 1973). Discussion of the possible practical utility of
this property of muscle suggested that stretch results in a longer,
not a stronger muscle fiber; that is, stretch does not result in
an increase in cross-sectional area of muscle, which is a key
parameter in muscle strength. While muscle atrophy may be retarded
in the stretched muscles, atrophy of their antagonists, placed in
the shortened mode, may be accelerated (Fournier et al., 1983;
Simard et al., 1982; Spector et al., 1982). Stretching of muscles
was not considered a practical approach to intervention of muscle
atrophy associated with space flight.
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The time course of recovery of muscle strength following
injuries or neurologic disorders appears to differ from that of
muscle bulk. Strength frequently returns in a matter of weeks,
provided suitable exercise is used. However, when a limb has been
immobilized for a short period for orthopedic reasons, it is very
difficult to rehabilitate the atrophic muscles to normal bulk
(Danckwardt-Lilliestrom and Sjogren, 1976; Salter, 1957).
Documentation of the degree of decrement in endurance of
the leg muscles of astronauts appears to be limited, suggesting
that additional pre- and postflight measurements should be made.
Opinion varied as to whether significant changes in muscle strength
and endurance would occur during 7-10-d space flights. For exam-
ple, the estimated rate of muscle protein synthesis in the hind
limbs of rats declined 37% after 6 h of limb immobilization, sug-
gesting to the authors that very early changes occur in molecular
events that regulate protein synthesis in disused or immobilized
muscle (Booth and Seider, 1979). Krieger et al. (1980) reported
that immobilization of rat hind limbs for 2 d resulted in a
decrease in state III respiration and the respiratory control
index of the sarcolemmal, but not the intermyofibrillar, mitochon-
dria of gastrocnemius muscles. However, there are no reports of
such short-term changes in strength and endurance performance of
immobilized muscles in the rat. Moreover, it appears that endur-
ance properties of muscles change little after prolonged limb
immobilization in such species as the guinea pig (Maier et al.,
1976), rat (Witzmann et al., 1983), and subhuman primate (Edgerton
et al., 1975). Human subjects exposed to simulated weightlessness
for 7 d by means of immersion in water demonstrated a 30-40%
decrease in maximum dynamic and isokinetic strength of the leg
extensors and in the isokinetic strength of the tibial muscles
(Grigor'yeva and Kozlovskaya, 1983). The authors regarded these
rapidly developing changes as reflexive responses to the removal
of load bearing. Since little is known about the time of onset
and rate of progression of muscle atrophy in space flight, a major-
ity of the participants favored taking advantage of opportunities
for such studies in the Space Shuttle Program (see also p.30, 31).
Review of the Skylab data indicated that exercise with
the bicycle ergometer apparently reduced the amount of leg atrophy
to be expected, but it was considered an inefficient method com-
pared with other types of exercise made possible by devices such
as the "treadmill" equipped with elastic tiedowns for the user
(see p.18). There was general agreement that inflight exercises
for astronauts should include types for maintaining both strength
and endurance. Two-to-three d/wk would probably suffice for
strength-building exercises, and another 2-3 d/wk for endurance
training.
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2. Electrical stimulation
Animal and human studies have demonstrated that
electrical stimulation of inactive muscle, such as exists in
denervation or immobilization, can retard and perhaps prevent
muscle atrophy (Fischer, 1939; Grodins et al., 1944a,b; Herbison
et al., 1971; Kosman et al., 1947a,b, 1948; Laughman et al., 1983;
Shaffer et al., 1954; Stillwell and Wakim, 1962; Wehrmacher et al.,
1945). With regard to space application, Soviet investigators
reported beneficial effects of electrostimulation of muscles in
human subjects exposed to prolonged simulated weightlessness
(Kakurin et al., 1973; Georgiyevskiy et al., 1979). Daily electro-
stimulation of the muscles of the abdomen, back, thighs and legs
during a 45-d bed-rest experiment was credited with favorable
effects on muscle "tone", strength, and static and dynamic endur-
ance. Soleus muscle biopsies showed a "positive effect of electro-
stimulation ... preventing development of the atrophic process"
(Kakurin et al., 1973). In a similar study, 8 of 12 healthy volun-
teers received electrical stimulation of the anterior and posterior
muscles of the legs and thighs as well as back and abdomen for
2 daily 30-min periods, six times/wk while remaining at bed rest
for 45 d in a 6.5° head-down tilt position (Georgiyevskiy et al.,
1979). Although all subjects showed decreases in circumferences
of legs and thighs as measured on day 40 of the experiment, the
mean change in the stimulated group was significantly less than in
the controls. The authors noted that the "general condition and
endurance ... were better among individuals whose muscles were
submitted to stimulation." It is understood that electrostimula-
tion is used operationally in the Soviet space program as a part
of their system of countermeasures against the adverse effects of
space flight.
After discussion, the ad hoc Group considered that elec-
trostimulation is not a useful technique for prevention of muscle
degradation during space flight, for several reasons: (1) volun-
tary contraction of muscle is the most efficient and physiologic
means; (2) the intensity of electric current required to produce a
maximum contraction is intolerable in most subjects; and (3) the
fact that the effectiveness of electrostimulation is dependent
upon the electric impulse density, which, in muscle, diminishes
markedly only 10 mm from the point of stimulation. The use of
pad electrodes applied to the skin would probably result in stimu-
lation of only the superficial fibers in a muscle.
However, it is possible that electrically-induced muscle
contractions employing easily tolerated amounts of current may
offer some advantage in terms of sensory perception of the associ-
ated limb movement, a sort of biofeedback to train individuals to
contract their muscles maximally.
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3. Other approaches
Other ideas that were mentioned include the possible
utility of a motion-resistive carapace or exoskeleton for wear by
space flyers, and pharmacologic or biochemical means of interven-
tion. Soviet authorities advocate use of a load suit except
during hours of relaxation and sleep (Gurovskiy et al., 1975).
This garment, which is known as the "Penguin" suit, is said to pro-
vide partial compensation for zero-G by opposing body movements
and simulating a constant gravitational load on the muscles of the
trunk and legs (Nicogossian and Parker, 1982).
Leucine possesses some apparently unique regulatory and
metabolic properties in muscle, including the promotion of protein
synthesis and inhibition of protein degradation (Goldberg and Chang,
1978). These properties of leucine and possibly of combinations
of other BCAA may offer an experimental approach to a dietary or
biochemical method of intervention (Goldberg and Chang, 1978;
Goldberg and Tischler, 1981; Morgan et al., 1981; Stewart et al.,
1982). Stewart et al. (1982) administered a mixture of branched-
chain ketoacids to patients with Duchenne muscular dystrophy and
observed a reduction in the rate of excretion of 3-methylhistidine
(3-MeH) in the urine. The authors concluded that the mixed keto-
acids reduced muscle protein degradation acutely in their patients.
Finally, pharmacologic intervention by use of inhibitors
of proteolysis has stimulated interest in laboratory experimenta-
tion in disorders such as muscular dystrophy. It has been reported
that microbial anti-proteinases such as antipain, leupeptin, and
pepstatin inhibit degradation of denervated pectoralis muscle in
chickens (Stracher et al., 1979) and chicken dystrophic muscle in
tissue culture (McGowan et al., 1976). Schorr et al. (1978)
reported beneficial effects of treatment of dystrophic mice with
pepstatin, starting at 3 wk of age and continuing for 5 wk. How-
ever, Enomoto and Bradley (1977) found no evidence of suppression
of muscle degeneration in dystrophic mice given subcutaneous injec-
tions of leupeptin and pepstatin during their remaining life spans
starting at age 35 d. On the contrary, there is some suggestive
evidence that, for example, elevations in lysosomal proteases (for
which a few inhibitors are available) result from muscle regenera-
tion, not muscle degradation (Griggs and Rennie, 1983; Stauber,
1980). On this basis, administration of an inhibitor could con-
ceivably interfere with the process of muscle protein synthesis,
an event presumed to be beneficial in recovery from muscle atrophy.
Thus, there is currently little scientific basis for the use of
protease inhibitors to prevent disuse atrophy in man; however, the
subject deserves further investigation.
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4. Research suggestions
A careful analysis of available data on the effec-
tiveness of eccentric muscular contractions in terms of physical
fitness training and rehabilitation of atrophic muscle should be
done. If eccentric exercise has some advantages over other modes
for maintenance of strength and endurance, its use as an inflight
mode should be investigated, including studies with human subjects
exposed to simulated space flight. Prospective investigators
should be aware of the availability of versatile exercise devices
whose operating modes include eccentric exercises. For example,
see Knuttgen et al. (1982).
Biochemical, neurophysiologic, and other properties of
muscle during adaptation to eccentric loading should be determined
in an animal model to complement the human studies suggested above.
To acquire data for use in improving inflight exercise
regimens, pre- and postflight measurements of maximal voluntary
contraction of the flexors and extensors of the arms and legs
should be done on all personnel who participate in space flights.
Such measurements should be made despite the idea that missions
lasting only 7-10 d probably induce little muscular deconditioning.
The importance of matching the test methods to the types of exer-
cises used should be kept in mind.
Skylab data suggest that exercise with the bicycle ergom-
eter at a level of 80 watt-min/d/kg LBM (4.8 kJ/d/kg LBM) main-
tained thigh muscle mass, but 100 watt-min (6kJ) was required to
prevent atrophy of the calf muscles (Whittle, 1979). If possible,
ground-based studies should be devised to determine the reasons
for this difference. Hopefully, the derived information could be
applied to improving inflight exercise devices and regimens.
A human, ground-based study should be considered for
determining the minimum amounts of strength or endurance exer-
cises, or combinations of these, needed to prevent muscle atrophy
in a model of hypokinesia.
Possible modifications of available inflight exercise
regimens and devices should take into account the need to control
or prevent all responses to zero-G that might benefit from various
types and amounts of exercise including cardiovascular decondition-
ing, muscle atrophy, fluid shifts, and, possibly, the space sick-
ness syndrome and bone demineralization. With regard to the
latter, the pronounced negative calcium balance of space flight is
the subject of a parallel study by LSRO, to be published under the
title, "Research Opportunities in Bone Demineralization", edited
by S.A. Anderson and S.H. Cohn.
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Human as well as animal studies of the possible prevent-
ive benefit of supplements of leucine and/or combinations of iso-
leucine and valine should be done in models of disuse atrophy. A
complementary effort should be considered to determine whether the
effect of leucine on protein synthesis is sustainable for a pro-
longed period or is limited to an acute response. Similar data
should be sought regarding the effect of metabolites of leucine on
proteolysis.
Animal studies should be expanded to assess the possible
preventive value against disuse atrophy of administering inhibitors
of myofibrillar proteases and other proteases involved in muscle
protein turnover. Part of such investigations should be identifi-
cation of untoward side effects, which could be more onerous than
the disuse atrophy itself.
Speculation about possible reduction of sensory perception
of muscle contraction during space flight suggested a need for an
expert analysis of available data on this subject (see p.38). If
this were identified as a significant problem in achieving optimum
muscular contraction during inflight exercises, electrical stimula-
tion of muscles could be considered as a method for increasing sen-
sory perception.
Finally, the report of Sale et al. (1982) that muscle "...
training prior to immobilization provided a reserve of neuromuscu-
lar function (reflex potentiation) which attenuated the effect of
immobilization in relation to the control conditions" suggests a
need for more data on this type of approach. In addition, NASA
scientists should consider reexamining available data from ground-
based and space flight studies to explore relationships among:
(1) physical fitness training before and during real and simulated
weightlessness; (2) postexposure exercise capacity, orthostatic
tolerance, and +GZ acceleration tolerance; (3) the muscle decondi-
tioning response; and, (4) the cardiovascular deconditioning
response. This should include consideration of the data reviewed
by Klein et al. (1977) and data presented by Goldwater and Sandier
(1982) suggesting an inverse relationship between aerobic fitness
and tolerance for gravitational loads. Such an analysis may aid
in resolving questions about optimal physical fitness and exercise
regimens for space flyers.
E. MODELS, METHODOLOGY, AND EQUIPMENT
1. Models
The question of the most suitable models for investi-
gating muscle atrophy related to space flight received considerable
emphasis during the ad hoc meeting. This involved techniques of
simulating hypokinesia and weightlessness in human and animal
experiments, the best animal models, and the lack of acceptability
of the much-used term "disuse" atrophy.
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True disuse of motor units typically results from inter-
ruption of motor nerve input to the muscle and features electri-
cally silent myoneural junctions. Thus, models of "disuse" based
on such techniques as denervation do not realistically simulate
the situation in space flight where the innervation remains
intact. Again, with the intact neuromuscular system as one cri-
terion, mechanical immobilization cannot truly be a model of dis-
use in that voluntary contractions of the involved muscles occur
(Fournier et al., 1983). It is apparent, therefore, that space
flyers experience a reduction in the amount and force of activity
of the musculature that probably should be thought of as a type of
"under-use". For studies with human subjects, the best, currently
available, ground-based model appears to be bed rest with physical
activity ranging from minimal to specific schedules of exercise or
postural changes, depending on the experimental objectives.
To date, the best animal model for simulating the hypo-
kinesia and hypodynamia of weightlessness appears to be the rat
model in head-down tilt that unloads the hind legs (Feller et al.,
1981; Morey-Holton and Wronski, 1981; Musacchia et al., 1983).
The head-down tilt is achieved by tail suspension or a body har-
ness. According to unpublished information presented during the
meeting, comparisons of atrophic effects from experiments with the
head-down tilt model, other models of "disuse", and from space-
flown experiments suggest the head-down tilt model produces
reasonably good simulation of weightlessness in the rat's hind
legs. The usefulness of this model for studying changes in body
composition has not been validated.
Although mechanical immobilization of joints is widely
used as a means of producing "disuse" atrophy, it was not con-
sidered a good model for simulating the physical conditions of
space flight. Nevertheless, its utility was acknowledged as a
means of inducing muscle atrophy for various sorts of investiga-
tion in muscle biology including, for example, testing of techni-
ques of intervention. Moreover, when muscle atrophy resulting
from space flight becomes better characterized at both the macro-
and micro-levels, mechanical immobilization may prove to be a
valid research model for studies of space-related muscle atrophy.
Two other models were suggested as advantageous for
certain types of studies. Human patients or animal models with
spinal cord damage could provide, during certain intervals after
injury, an excellent model of true disuse atrophy which could be
used for special studies such as determining the minimum amount of
electrically-induced exercise needed to prevent atrophy. Data of
this sort could then be used in formulating optimum voluntary
exercises for use in weightless flight.
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The other model of a pure disuse atrophy involves pharma-
cologic blockade of motor nerves with tetrodotoxin, which blocks
nerve impulses but not fast axonal transport (Drachman et al.,
1982a,b). Otherwise, the neuronmscular anatomy and physiology
apparently remain unchanged, but the resulting muscle atrophy
matches that of denervation. Again, this may prove to be a useful
animal model for space-related studies if it can be validated by
data from studies with other models including space-flown rats and
the rat head-down tilt model.
Training muscle groups to a level of hypertrophy, then
stopping training and measuring various parameters such as rate
of reversion to pre-training status may roughly simulate the
effects of under-use of muscles during weightlessness and is appli-
cable for human and animal experiments (Houston et al., 1979). A
similar model could be used to measure changes in muscle groups
trained for endurance (Faulkner et al., 1972); however, evidence
is limited that fatigability of muscle increases during space
flight or after immobilization.
Other models that are considered useful for investigation
of muscle atrophy involve tissue culture, organ culture, and
partial-body perfusion techniques such as hemiperfusion and isola-
ted, perfused muscle preparations. As is known, experiments based
on tissue culture or perfusion techniques in which the tissues are
homogenized and then measured for incorporation or disappearance
of a marker sometimes yield data of questionable validity because
of confounding problems such as the reutilization of amino acids
from degradation of muscle proteins in experiments on muscle atro-
phy. A problem in using isolated, incubated muscle preparations
is hypoxia or anoxia of the deeper portions if the muscle is too
thick; insufficient tissue oxygenation for cells beyond those on
the surface introduces uncontrolled variables. Nevertheless, cer-
tain types of muscle studies involving tissue culture (Ewton and
Florini, 1981; Florini et al., 1977), organ culture or hemicorpus
perfusion (Goldberg and Chang, 1978; Goldberg et al., 1980a;
Jefferson et al., 1972; Li and Jefferson, 1978) have produced
valuable data.
In summary, although all the models discussed have short-
comings in terms of simulating the environment of space flight and
other technical flaws, those offering certain investigative advan-
tages are identified in the foregoing. While no model is ideal, a
better understanding of the nature, causes, and mechanisms of
space-related muscle atrophy will permit refinement of experimental
models for both ground-based and inflight studies.
2. Methodology and equipment
Some methods for measuring muscle strength and endur-
ance fail to take into account the accessory action of all muscle
groups involved. For instance, the contribution of the iliopsoas
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and trunk muscles to extension and flexion of the knee is often
included with strength values credited solely to the quadriceps
and hamstrings. Definitions, methods, and apparatus seem to need
improvement.
Muscles that are feasible to study in human subjects in
terms of relatively isolatable EMG signals include the biceps
brachii, triceps brachii, quadriceps, hamstrings, tibialis anticus,
and gastrocnemius. In addition, muscles whose customary levels of
activity would, presumably, not change significantly in zero-G
offer useful models for comparison with muscles that are known to
atrophy. Examples suitable for human studies include the masseters
and temporalis muscles (provided that a normal amount and strength
of chewing occur inflight), and, for animal studies, the diaphragm,
anal and bladder sphincters.
The practicality of using 3-MeH as a method of following
muscle protein degradation was discussed. 3-MeH has been called a
unique marker because during the breakdown of muscle proteins it
is released and excreted unchanged and quantitatively in the urine,
not being reutilized for protein synthesis or oxidized for energy.
Recent examples of reports on the method and its advantages and
possible shortcomings include Afting et al. (1981), Anonymous
(1983), Elia et al. (1981), Long et al. (1981), Millward et al.
(1980a,b), Ward and Buttery (1978), Wassner and Li (1982), and
Young and Munro (1978). Certain problems call for caution in
interpreting 3-MeH excretion data. First, endogenous sources of
3-MeH other than muscle are becoming better recognized, such as
skin and gastrointestinal tract (Long et al., 1981). As much as
40% of 3-MeH excreted in urine may be derived from sources other
than skeletal muscle. Second, dietary sources such as meats per-
turb the normal rates of excretion; and, third, the values for
normal rates of excretion may not be as well established as they
should be for quantitative use (Long et al., 1981). In addition,
little is known about diurnal variation in 3-MeH excretion and the
influence of exercise.
The meeting participants regarded the 3-MeH method as
useful in studies of muscle atrophy provided that (1) dietary
intakes are either excluded or quantified; (2) an allowance is
made for other known endogenous sources in the species under
investigation; and (3) other measures of protein breakdown are
included, such as nitrogen balance data (e.g., total nitrogen
and urea excretion), measures of lean body mass, and creatinine
excretion.
Members of the Group advised that in ground-based stud-
ies, care should be used to simulate the force-velocity parameters
of muscle function in space flight. The fact that data on this
are very limited reemphasized the prominent need for inflight
measurements.
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A method for human studies of interest to short-term
missions and having such advantages as simplicity, relatively low
expense, and "built in" controls, might involve bed rest with or
without casting of one lower extremity (one-leg model) for 2 wk.
During this period different types and schedules of voluntary exer-
cise would be included for the control (nonimmobilized) leg along
with comparative measurement of strength, endurance, and other
parameters of both legs. For instance, such one-leg models have
been useful in investigating the adaptive responses of human skele-
tal muscle to exercise (Saltin et al., 1976).
With respect to equipment and devices, discussion focused
on: (1) the excellence of currently available miniature electrodes,
sensors, and recorders for noninvasive acquisition of signals such
as EMG; (2) means of gross measurement of muscle atrophy, strength,
and limb motion; and, (3) the increasing numbers and variety of exer-
cise devices that are of interest to biological scientists, clini-
cians, and specialists in physical training. Devices designed for
research in both concentric and eccentric exercise modes have been
described by Knuttgen et al. (1982) and Knutsson (1983).
The accuracy of assessing muscle atrophy by measuring
changes in limb circumference and volume is somewhat limited
because of masking by fat, extramuscular connective tissue, and
changes in extracellular fluid volume. While such methods have
their uses, they are inadequate for obtaining precise quantitative
data and have been associated with underestimating amounts of mus-
cle atrophy (Young et al., 1980; 1982).
3. Research suggestions
Methods and devices for measuring muscle strength,
endurance, and velocity in different exercise and test modes
should be improved for application to specific research on space-
related muscle atrophy. Objectives should include simplification,
ease-of-use, and miniaturization. More attention should be given
to noninvasive means of improving the gross measurement of muscle
atrophy. Promising methods that may aid in measuring muscle mass
and dimensions include computer-assisted tomographic scanning
(Ingeman-Hansen and Halkjaer-Kristensen, 1980), ultrasonography
(Young et al., 1980), and nuclear magnetic resonance imaging.
To acquire necessary data to be used for identifying the
most appropriate research model for investigating the effects of
weightlessness on muscle, the following parameters should be
measured in normal rats and in the several models of "disuse"
atrophy that have been chosen by investigators: EMG, force, and
velocity of movement of the dorsi- and plantarflexers of the feet
over 24-h periods. The models should include immobilization by
casting and by pinning (Fischbach and Robbins, 1969; Fournier
et al., 1983), head-down tilt by tail suspension or body harness
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(Feller et al., 1981), paraplegia, specific muscle group denerva-
tion, and specific pharmacologic nerve block by tetrodotoxin intro-
duced subperineurally (Drachman et al., 1982a). These studies
would be the ideal experiments. They would determine whether any
of the above models is adequate to help understand space-induced
atrophy by matching these results with those from space-flown
rats. Comparisons also can be made with the experiments on astro-
nauts. One problem is that not all of the above measures can be
made effectively on rats. However, some strategic compromises can
be made to make this experiment possible.
Because of the unique properties of 3-MeH as a convenient
marker for muscle protein degradation, and in view of a scarcity
of data on its behavior in such situations as heavy resistance
exercise, endurance exercise, eccentric versus concentric contrac-
tions, and possible diurnal effects on its excretion rate, addi-
tional studies should be considered.
With respect to rehabilitation of atrophic muscles it is
likely that the same types of exercise recommended for inflight
use should be used for rehabilitation. With regard to choices of
exercises some variables that should be taken into account are:
(1) level of neuromuscular activation, (2) frequency of contrac-
tions, (3) number of contractions, and (4) the effect of lengthen-
ing versus shortening contractions. The suggestive evidence that
eccentric contractions may be advantageous should be investigated
(see p.59).
F. THE NASA RESEARCH PROGRAM IN MUSCLE ATROPHY
Three documented components of NASA's programs of research
and analysis in muscle atrophy and muscle biology came to the atten-
tion of the LSRO ad hoc Working Group on Muscle Atrophy: (1) the
formally programmed Research and Technology Objectives and Plans
(RTOP) document, No. 199-20-42, Muscle Atrophy; (2) several univer-
sity-based studies in NASA's Space Biology Program; and, (3) one
human and three rat experiments scheduled for Spacelab 4. Table 4
lists summary information on the Biomedical Research Program on
Muscle Atrophy. In addition, as parts of other activities includ-
ing the flight program of the Space Transportation System (Space
Shuttle), NASA develops and tests exercise devices and regimens,
personal protective/life support equipment and suits, and plans
and conducts space medical tests and observations of the astro-
nauts that yield data of interest to the biomedical problems of
space flight, including muscle atrophy.
The ad hoc Group was concerned mainly with that part of
NASA's Biomedical Research Program dealing with muscle atrophy.
However, it recognized the potential of the parallel activities
mentioned above. The overall program appears well conceived to
embrace the key objectives and research approaches needed for
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Table 4. The NASA Biomedical Research Program in Muscle Atrophy
1. Proteolysis in muscle atrophy (Task -01). The objective of
this task is to define the basic proteolytic enzymes, pathways,
and regulatory mechanisms involved in disuse atrophy of skeletal
muscle. Current emphasis is on the role of specific lysosomal
and nonlysosomal muscle proteases in muscle atrophy. A future
study will attempt to localize tripeptidyl aminopeptidase (TAP)
in muscle, relate various prostaglandins to lysosomal behavior
and control of TAP content, and determine the effect of disuse
atrophy on concentrations of Ca2+_activated proteases.
Principal Investigator: S. Ellis, NASA Ames Research Center.
2. Growth factors and muscle atrophy (Task -02). The objective
is to test the hypothesis that disuse atrophy results from a
deficiency of specific growth factors originating in the nerves
of muscles undergoing atrophy. Current studies examine the
responses of cultured chick myoblasts to highly purified neuro-
trophic factor (NTF) (Popiela and Ellis, 1981), and future
efforts will: (a) investigate the presence of growth factors
and inhibitors in normal, hypertrophic, and atrophic muscle;
(b) determine the effects of rat and rabbit NTF on cultured
chick myoblasts; and, (c) titrate the sensitivity of protein
synthesis and degradation as influenced by insulin in muscle
undergoing atrophy. Principal Investigator: S. Ellis, NASA
Ames Research Center.
3. The role of bioassayable growth hormone in protein balance
(Task -03). The objective is to clarify the role of growth
hormone in protein balance by isolating and characterizing the
major circulating forms and developing a radioimmunoassay (RIA).
Future studies will employ the RIA to measure the hormone in
rats that have been suspended, exercised, centrifuged, protein-
depleted, or treated with growth hormone releasing factor.
Principal Investigator: R.E. Grindeland, NASA Ames Research
Center.
4. Gonadal steroids and muscle atrophy (Task -06). The objec-
tive is to elaborate mechanisms that regulate muscle size by
means of an androgen-sensitive muscle in the rat, the levator
ani. The effects of androgenic or estrogenic hormones, or
their depletion, on the size of the levator muscle and its
testosterone receptor concentrations were studied. Future
effort will be devoted to: (a) the regulation of cytosolic
androgen receptors in muscle by sex steroids; (b) hormonal
regulation of glucose turnover in normal and atrophic muscle;
(c) oxidative metabolism in muscle following gonadectomy and
after hormone replacement; and, (d) the nature of estrogen-
androgen synergy in muscle. Principal Investigator: S. Max,
University of Maryland.
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Table 4. (cont.)
5. Muscle fiber type distribution relative to muscle weakness: a
new method (Task -07). The objective is to develop and vali-
date a method for determining fiber types in muscles of subhuman
primates. Percentages of fast and slow fibers in five skele-
tal muscles have been determined in monkeys by the differential
ratio of Sr^+/Ca^+ concentration for activation of tension.
Future effort will include analyses of muscle biopsy samples
from chaired and free-moving monkeys for fiber type and rayosin
heavy and light chain content. Principal Investigator: W.G.
Kerrick, University of Miami.
6. Mechanisms and control of disuse atrophy in skeletal muscle
(Task -10). The objective is to define the role of stretch in
the synthesis and activity of muscle contractile proteins and
sarcoplasmic reticulum. Organ culture of rat soleus muscle
was tested for viability and utility as a model for studying
various factors in muscle atrophy such as the influence on pro-
tein degradation, of aspirin or protease inhibitors, changes
in twitch kinetics, and the effects of stretch on proteolysis.
The studies will be continued along similar lines. Principal
Investigator: J.D. Etlinger, S.U.N.Y. Downstate Medical
Center, Brooklyn.
7. Biochemical adaptations of antigravity muscle fibers to disuse
atrophy (Task -12). The objective is to investigate the
molecular basis of disuse atrophy in the rat soleus muscle,
with emphasis on protein and carbohydrate metabolism. Rates
of synthesis of actin and cytochrome c were determined at the
sixth hour of limb immobilization; no change was found in the
level or activity of the reputed insulin mediator in the muscle
after 24 h of immobilization. Future effort will probe the
content of actin mRNA in the muscle during the first 6 h of
immobilization and determine whether a translation of actin
occurs during the same time period. Principal Investigator:
F.W. Booth, University of Texas Health Sciences Center, Houston.
8. Alterations in skeletal muscle with disuse atrophy (Task -13).
The objective is to characterize the adaptive responses of rat
skeletal muscle to moderate and prolonged disuse by hindlimb
immobilization, evaluate the role of motor activity in disuse
atrophy, and elucidate factors that influence recovery such as
the duration of immobilization, electrical stimulation, and
exercise. Data have been obtained on: (a) responses of the
soleus muscle to casting for 6 wk in the shortest possible
position; (b) temporal changes in twitch duration time; (c)
rates of recovery in terms of isometric twitch duration and
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Table 4. (cont.)
half-relaxation time; (d) changes in rates of Ca^+ uptake of
sarcoplasmic reticulum from slow soleus and two types of fast
vastus lateralis fibers. Future efforts will emphasize in vitro
studies of the contractile properties of single-skinned fibers,
changes in the light chains and sarcoplasmic reticular proteins,
and Ca^ "*" uptake and release kinetics of sarcoplasmic reticula
of the three atrophying muscle fiber types. Principal Investi-
gator: R.E. Fitts, Marquette University.
9. Immobilization/remobilization and the regulation of muscle mass
(Task -14). The objective is to determine the role of gluco-
corticoids in the responses of skeletal muscle to under-use
and disuse. Baseline data were developed in young, growing
rats on temporal changes in the sizes of the soleus and extensor
digitorum longus and on the following biochemical parameters:
(a) total protein; (b) total noncollagen protein; (d) total
collagen; (d) soluble protein; (e) total myofibrillar protein;
(f) myofibrillar noncollagen protein; (g) collagen in the myo-
fibrillar fraction; and (h) DNA content. Future studies will
determine glucocorticoid sensitivity of hindlimb muscles
during immobilization and recovery and, by in vitro methods,
analysis of atrophic muscle for glucose uptake, amino acid up-
take and incorporation, ribosomal activity, protein degradation,
glutamine and alanine production, and proteolytic activity.
Principal Investigator: R.R. Almon, S.U.N.Y. Buffalo.
10. The combined influence of stretch and mobility on muscle atrophy
caused by immobilization (Task -15). The objective of this
new task is to investigate physical factors that influence the
responses of skeletal muscle to immobilization. Factors to be
studied include: (a) passive stretch in relation to muscle
fiber development, physiologic performance, and protein turnover;
(b) minimum force and number of muscle contractions needed to
prevent atrophy; (c) effectiveness of negative, positive, and
isometric contractions in producing hypertrophy and preventing
atrophy of muscle fibers; and, (d) alterations in connective
tissues of muscles and tendons induced by immobilization and
inactivity. Principal Investigator: G. Goldspink, Tufts Uni-
versity School of Medicine.
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ultimate solution to the operational problem of muscle atrophy.
Periodic review of advancing knowledge in muscle biology and
closely related fields and appropriate revision of the program
will be an important, continuing activity of NASA management.
The Working Group took note of the muscle research in the
NASA Space Biology Program and the experiments that have been plan-
ned for Spacelab 4, all of which appear to increase NASA's poten-
tial to elucidate the mechanisms and resolve the problem of space-
related muscle atrophy. These researches are listed in Table 5.
The experiments in the Space Biology Program explore the effects
in rats of simulated weightlessness on: (a) the biochemical
characteristics of changes in fast and slow muscle, regulation of
acetylcholinesterase and other proteins involved in neuromuscular
transmission and their axoplasmic transport (Dettbarn); (b) mecha-
nisms of changes in protein/RNA relationships in hindlimb muscles
of the rat head-down tilt model, and glucocorticoid receptor levels
and sensitivities (Musacchia); (c) motor control including muscle,
motor neuron, and sensory components (Stuart); (d) histochemical
changes during atrophy and recovery, with emphasis on identifying
the most sensitive physiologic, histochemical, and biochemical
responses (Templeton and Sutko); and (e) the biochemical adapta-
tions of muscle to nonweight-bearing conditions including the fate
of excess amino acids liberated in muscle during atrophy and
studies of methods of preventing muscle atrophy, such as passive
stretch (Tischler).
In Spacelab 4, the human study (Stein) will examine the
effect of zero-G on whole-body protein metabolism in an effort to
establish whether the nitrogen loss is caused principally by
decreased uptake and production of protein or by increased mobili-
zation and metabolism of muscle protein. Measurements will include
rates and levels of incorporation of •'•^ N-glycine into various pro-
teins and hemoglobin and rates of urinary excretion of 3-methyl-
histidine, hydroxyproline, hydroxylysine and their glycosides.
Similar studies will be done in rats, but in addition, the animal
experiments will include morphologic changes in muscles and nerves
and biochemical analyses of muscle proteins. The effect of zero-G
on the capacity of both rested and exercised skeletal muscle for
oxidative metabolism will be investigated (Baldwin). Analysis of
skeletal myosin isoenzymes will facilitate a determination of pos-
sible shifts from slow- to fast-twitch muscle fibers (Hoh). Dr.
Ellis' experiments with rats in Spacelab 4 cover several physio-
logic, morphologic, biochemical, and histochemical aspects including
observation of inflight activity patterns, electromyography, ana-
tomic changes in slow- and fast-twitch muscle, assays of the pro-
teolytic and mitochondrial enzymes in the muscles, and an attempt
to differentiate the biologic effects in the anti-gravity muscles
and nerves of launch stress, inflight atrophy, reentry stress, and
late postflight recovery.
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Table 5. Muscle Research In Other NASA Programs
Title/Task No.
Principal
Investigator Institution
A. Space Biology Program
Weightlessness Simulation:
Physiological Changes in
Fast and Slow Muscle
W.D. Dettbarn Vanderbilt University
Renal Function, Water and
Electrolyte Balance, and
Intestinal Transport in
Hypokinetic Animals
Effects of Muscle Atrophy
on Motor Control
Influence of Suspension-
Hypokinesis on Skeletal Muscle
Skeletal Muscle Metabolism in
Hypokinetic Rats
X.J. Musacchia
D.G. Stuart
G.H. Templeton
and J.L. Sutko
M.E. Tischler
University of Louisville
University of Arizona
University of Texas,
Dallas
University of Arizona
B. Spacelab 4
Effect of Zero-Gravity on Biochemical
and Metabolic Properties of Skeletal
Muscle
K.M. Baldwin University of California,
Irvine
Electron Microscopy, Electromyography, S. Ellis
and Protease Activity of Rat Hind-
Limb Muscles
Skeletal Myosin Isoenzymes in Rats J.F.Y. Hoh
Exposed to Zero-Gravity
Protein Metabolism During Spaceflight T.P. Stein
NASA Ames Research Center
University of Sydney
University of Pennsylvania
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As noted during the meeting of the ad hoc Group, the Bio-
medical Research Program on Muscle Atrophy is young, and the
efforts of NASA program planners and managers to improve it within
the constraints imposed by limitations of budget, manpower, and
relative priority are recognized. The research tasks in this pro-
gram are generally consistent with the recommendations in two of
the more recent, formal advisory reports on NASA life sciences
(Bricker, 1979; Whedon, 1978). Research that was considered by
some members of the Working Group to be appropriate to the stated
objectives of the program included tasks -01, -10, -12, and -13.
Tasks containing some elements that appear to address the objec-
tives include -03, -06, and -07, and the newly-initiated task -15
appeared pertinent as outlined. In general, the program seems to
need sharper focusing on its stated objectives.
To aid in aligning the program in muscle atrophy with
NASA's scientific and technical requirements, research suggestions
are detailed in the preceding parts of Section V and in Section VI.
The suggestions are for the consideration of NASA planners in the
hope that incorporation of some of the described approaches may
improve the program and ultimately assist in resolving the issues
of space-related atrophy.
G. CONCLUSIONS
Muscle atrophy associated with short-term space flights
(e.g., 7-10 d), is apparently not grossly detectable by currently
available methods, nor is it a functional problem. Nevertheless,
in missions extending beyond approximately 3 wk, muscle atrophy
typically progresses to a level that, while nonincapacitating in
flight, may severely interefere with readaptation to 1-G. In
addition, it would probably compromise physiologic efficiency for
strenuous extravehicular activity.
Daily vigorous physical exercise inflight appears to
retard the atrophic process, but, despite this and other preven-
tive measures, nitrogen balance tends to remain negative or only
slightly positive; the negative nitrogen balance appears to result
from loss of lean body mass.
Unloading the musculature in weightlessness is generally
accepted as the cause of the muscle atrophy. However, the exact
biologic mechanisms involved in atrophy and hypertrophy of skele-
tal muscle are unknown even though a great deal of excellent
research has been done on the biology of muscle in the appropriate
disciplines. Since development of the optimum means of preventing
or controlling space-related muscle atrophy will depend on knowl-
edge of the mechanisms involved, NASA supports both intra- and
extramural research in muscle biology. In the opinion of the LSRO
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ad hoc Working Group on Muscle Atrophy, NASA should continue its
program, but with some changes in emphasis to assure better consis-
tency between ongoing and planned research and the carefully
composed, highly appropriate Research and Technology Objectives
and Plans on Muscle Atrophy (NASA RTOP 199-20-42).
As noted, particularly on pages 30, 31, the Working Group
strongly recommends inflight studies of certain muscle functions
of astronauts as soon as possible in the Space Shuttle Program as
essential for acquiring data with which to improve the design of
ground-based and inflight experiments and to determine the best
human and animal models of space-related muscle atrophy.
The points of emphasis, important gaps in knowledge, and
research suggestions presented in this report are submitted for
the consideration of NASA scientists whose responsibilities include
research program planning and management. Section VI summarizes
the research in tabular form, in a suggested order of priority.
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VI. SUGGESTIONS FOR FUTURE CONSIDERATION
The main objective of NASA's Research Program on Muscle
Atrophy is the acquisition of sufficient knowledge of its etiol-
ogy, pathogenesis, and underlying biologic mechanisms to enable
the development of efficient means of prevention. Consequently,
the LSRO ad hoc Working Group on Muscle Atrophy was concerned not
only with questions of basic research, but also with identifying
promising lines of applied research, operational flight testing,
and associated methodology and equipment.
NASA's current and planned research in this field, per-
haps modified and augmented by adoption of some of the suggested
research approaches in this report, should provide the necessary
knowledge for solution of the problem. However, shortcuts to dis-
covery of the basic mechanisms of space-related muscle atrophy are
unlikely to emerge. Therefore, muscle atrophy, which is a signifi-
cant biomedical problem of space flight, justifies a sustained,
vigorous program of research, including long-term studies, as a
part of NASA's major enterprises in space.
The suggestions of the ad hoc Group that are presented in
Section V are recapitulated in brief in Table 6. In each of the
four groups of categories shown in Table 6 (which differ inten-
tionally from the headings used in Section V), the suggested pri-
ority is in descending order from the top of each list.
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Table 6. Proposed Orders* of Priority of Research Suggested by
the ad hoc Working Group on Muscle Atrophy
A. BIOCHEMISTRY, ENDOCRINOLOGY, METABOLISM (see p.21-27; 29; 31-35)
• Mechanisms that induce muscle hypertrophy in exercise may
also be involved in muscle atrophy resulting from inactiv-
ity or under-use. Attempts should be made to identify
specific stimuli generated by exercise and to determine
how they signal the genes to induce protein synthesis.
• As one approach toward discovering basic mechanisms of
muscle hypertrophy and atrophy, the role of lysosomes in
muscle metabolism should be investigated from a broad
point of view.
• Additional studies of the effects on muscle of altered
levels of hormones and their receptor sensitivities
induced by models of hypokinesia/hypodynamia should be
encouraged. Test specimens may include incubated muscle
cells, incubated whole muscles, muscles in perfused
hemicorpus preparations, and intact muscles in vivo.
• Among substances that have regulatory roles in muscle
physiology that should be studied are growth hormones
and the somatomedins as well as insulin, corticosteroids,
and anabolic steroids.
• Additional studies are needed on the endocrinologic effects
of exposure to weightlessness and simulated weightless-
ness combined with hypokinesia/hypodynamia.
• Uncertainties about the rate of onset, degree, and dura-
tion of negative nitrogen balance in weightless flight
suggest a need for additional human metabolic balance
studies inflight.
* Listed in order of decreasing priority in each separate category.
For convenience of presentation the categories in this table differ
from the headings used in Section V.
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Table 6. (cont.)
B. NEUROPHYSIOLOGY AND KINESIOLOGY (see p.27-31)
Measurements of certain physical activities of astronauts
during typical days preflight and inflight are needed for
further definition of the nature of space-related muscle
atrophy and for development of suitable models for ground-
based and inflight animal studies. Electromyograms of
quadriceps, hamstrings, dorsi- and plantarflexers of the
feet; heel and metatarsal pressures, and movements of
selected joints such as knee, ankle, and elbow should be
included.
Levels of neuromuscular output of the astronauts should
be determined before, during, and after space flight by
measuring maximum force at zero velocity for the knee
extensors, knee flexors, and the dorsi- and plantarflexors
of the foot. This and the immediately preceding experiment
can be done with trivial imposition on the astronauts'
time by means of fully developed techniques and equipment.
A more nearly functional measurement than that in the
immediately preceding suggestion would be to test the
astronaut's ability to exert a maximum force at a selec-
ted velocity or, better, to produce a target force at a
selected velocity. However, this would require more of
the astronauts' time and additional development of
equipment.
Neuromuscular fatigability during space flight should be
evaluated for further characterization of muscle atrophy.
This can be done by measuring the maximum force that can
be produced over a span of 2 min while exerting a maximal
contractile effort every second. The electromyogram
should be recorded simultaneously. The measures should
be made preflight, inflight within a week of launch, and
as soon as possible postflight.
Three properties of skeletal muscle that should be con-
sidered for study in the rat model of hypokinesia/hypo-
dynamia (e.g., the tail-suspension model) are: resting
membrane potential, extrajunctional acetylcholine recep-
tors, and isometric strength in anti-gravity and nonpos-
tural muscles.
57
Table 6. (cont.)
Analysis of blood samples obtained during arm exercises
aloft could provide an indication of significant changes
in metabolic potential of the exercised muscle groups.
Such data would help to characterize space-related muscle
atrophy.
The influence of neuronal circuits proximal to the motor
unit on maintenance of muscle integrity and strength
should be studied in models of hypokinesia/hypodynamia.
C. MODELS, METHODOLOGY, AND EQUIPMENT (see p.41-46)
The electromyogram, force, and velocity of the dorsi- and
plantarflexers of the feet should be evaluated over
periods of 24 h in normal rats and in various rat models
of "disuse" atrophy including limb casting, joint pinning,
head-down suspension, paraplegia, denervation of specific
muscle groups and nerve block by tetrodotoxin. Results
of such studies would help to identify an adequate
research model for muscle atrophy.
Additional investigations of the utility of 3-rnethylhisti-
dine as a marker of protein degradation in muscle atrophy
should be done, including acquisiton of more normative
data on urinary excretion rates and the effects of diurnal
influences and exercise on excretion rates.
Human patients with spinal cord damage could provide,
during certain known intervals after injury, a model of
disuse atrophy suitable for special studies such as
determining the minimum amount of electrically-induced
exercise needed to prevent muscle atrophy. Such data
could be used to formulate improved inflight exercise
regimens.
An animal model of pure disuse atrophy that apparently
preserves the integrity of motor innervation employs
pharmacologic blockade of a motor nerve by subperineural
injection of tetrodotoxin. All physiologic and morpho-
logic properties of the nerve apparently remain normal
except for nerve impulse transmission.
58
Table 6. (cont.)
Another technique that may offer some advantages in
investigating muscle atrophy involves training muscle
groups to a level of hypertrophy, then ceasing training
and observing various parameters during the period of
reversion to pre-training status.
Methods and devices for measuring muscle strength, endur-
ance, and velocity in different exercise and test modes
should be improved for application to specific research
on space-related muscle atrophy.
D. COUNTERMEASURES (see p.35-41)
To acquire data for use in improving inflight exercise
regimens, pre- and postflight measurements of maximal
voluntary contraction of the flexors and extensors of the
arms and legs should be done on all personnel who partici-
pate in space flights.
A human, ground-based study should be considered for
determining the minimum amounts of strength or endurance
exercises, or combinations of these, needed to prevent
muscle atrophy in a model of hypokinesia/hypodynamia such
as bed rest.
Human and animal experiments should be performed to
determine possible preventive effects of dietary supple-
ments of leucine, combinations of isoleucine and valine,
or mixtures of the keto-analogues of leucine, valine, and
isoleucine in models of muscle atrophy induced by hypo-
kinesia/hypodynamia.
An expert analysis of available data should be done on
the effectiveness of eccentric muscular contractions in
physical fitness training and in rehabilitation of
atrophic muscles. If eccentric exercise appears to be
superior to other modes, its possible advantages as an
inflight mode should be investigated.
Biochemical, neurophysiologic, and other properties of
muscle during adaptation to eccentric loading should be
determined in an animal model to complement the human
studies suggested above.
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Table 6. (cont.)
Animal studies should be expanded to assess the possible
preventive value against disuse atrophy of administering
inhibitors of myofibrillar proteases and other proteases
involved in muscle protein turnover. Such experiments
should include a careful search for untoward side effects.
Additional human studies are needed to evaluate the
effects of preflight physical fitness training on pre-
serving neuromuscular function inflight and retarding mus-
cular deconditioning. Such data would aid in resolving
the debate between those who advocate peak physical condi-
tioning preflight and those who are convinced that inflight
resistance to muscular deconditioning is inversely related
to physical fitness.
If possible, ground-based studies should be devised to
determine the reason for observed differences in main-
taining leg muscle strength and preventing leg muscle
atrophy during Skylab missions, of bicycle ergometer
exercises at a level of 80 watt-min (4.8kJ)/d/kg lean
body mass versus 100 watt-min (6kJ)/d/kg lean body mass.
Possible reduction of sensory perception of voluntary mus-
cle contraction during space flight suggests a need for
an expert analysis of available data on this topic. If
this were identified as a significant problem in achieving
optimum muscular contractions during inflight exercises,
means of improving such perception could be evaluated,
such as electrostimulation of muscles.
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